Every nucleated cell in the body operates on an internal clock. That clock does far more than govern sleep and wakefulness. It helps determine which genes are accessible at different times of day, which biological pathways are prioritized, and how energy metabolism, inflammation, and cellular repair are coordinated over time. In this way, circadian rhythms function less like background physiology and more like a biological timing system for gene expression.

Genes are not read continuously. They are turned on and off in rhythmic patterns, shaped by signals such as light exposure, eating timing, and sleep-wake regularity. These signals interact with the epigenetic machinery that controls chromatin structure and transcriptional access. Over time, they influence whether metabolic, inflammatory, and mitochondrial pathways remain synchronized or drift toward dysfunction.

Chrono-epigenetics describes the intersection between biological time and gene regulation. It offers a framework for understanding how circadian rhythms help determine which genetic programs are expressed, when they are expressed, and why those timing decisions matter for long-term health.

The molecular clock is more than a timekeeper

At the core of circadian biology is a molecular system often described as a transcription-translation feedback loop (TTFL), where the underlying concept is that certain genes help regulate their own activity across an approximate 24-hour cycle.

Two of the central players in this system are CLOCK and BMAL1. These proteins pair together and bind to DNA, where they act as transcriptional activators. Their role is to turn on a large network of hundreds to thousands of downstream genes involved in metabolism, inflammation, mitochondrial function, cellular repair, and stress responses. These downstream genes are expected to be expressed rhythmically, with peaks and troughs aligned with predictable environmental demands.

Many of these genes (PER1, PER2, PER3, and CRY1, CRY2) encode proteins that, in turn, feed back to suppress CLOCK-BMAL1 activity, creating a daily rhythmic cycle of activation and repression. This negative feedback loop is what gives cells a sense of biological time.

A quick primer on gene expression

To understand how circadian rhythms influence gene expression, it is helpful to clarify what gene expression entails.

Genes are encoded in DNA, but DNA does not float freely inside the cell. It is tightly packaged around proteins called histones, forming a complex structure known as chromatin.

Transcription copies DNA into messenger RNA (mRNA), which then serves as the template for the synthesis of enzymes, receptors, transporters, and structural components that carry out physiological functions.

Chromatin as a timing gate

Circadian clock proteins such as CLOCK and BMAL1 regulate transcription by precisely modifying chromatin structure. By adding or recruiting enzymes that add specific epigenetic marks, they create windows of accessibility, which are periods during the day when certain genes can be transcribed efficiently.

This is how circadian rhythms become embedded in gene expression. The clock does not merely send signals downstream; it reshapes the genome’s physical landscape over time.

A NOTE ON CLOCK: This variation is associated with hyperglycemia, dyslipidemia, and an increased risk of T2DM. Specific variants, such as rs4580704 and rs1801260, have been linked to obesity, metabolic syndrome, and altered energy intake. In contrast, others are associated with bipolar disorder, reinforcing the convergence of circadian timing, metabolic regulation, and affective stability.

CLOCK itself has histone acetyltransferase activity, meaning it can directly add acetyl groups to histones, loosening chromatin and permitting transcription. BMAL1 recruits additional epigenetic enzymes that place or remove histone methylation marks, helping to determine:

• which genes are accessible,

• at what time of day,

• and for how long.

In practical terms, circadian rhythm creates time-restricted windows of chromatin accessibility. During these windows, specific gene programs can be transcribed efficiently. Outside of them, transcription is suppressed or energetically costly.

Why timing of transcription matters biologically

Cells are energy-limited systems. Producing proteins is metabolically expensive, and many biological processes depend on coordination rather than constant activity.

Circadian regulation of transcription allows cells to prioritize energy use, separate competing processes such as metabolism and repair, synchronize mitochondrial activity with demand, and temporally restrain immune signaling.

When transcription is temporally organized, physiology is efficient. When this organization is lost, systems begin to interfere with one another.

For example, expressing metabolic genes during the biological night when mitochondrial readiness and hormonal context are mismatched can increase oxidative stress and impair insulin signaling. Similarly, inflammatory gene expression that loses its rhythmic restraint can contribute to chronic low-grade inflammation.

From chromatin regulation to clinical patterns

This is why chromatin regulation is not an abstract molecular detail. It is the mechanism through which environmental timing signals, including light, food intake, and sleep-wake patterns, are translated into long-term physiological outcomes.

When circadian rhythms are stable, epigenetic control of chromatin ensures that transcription occurs in the right sequence and context. When rhythms are disrupted, chromatic accessibility becomes mistimed. Genes may still be expressed, but without the temporal structure that supports metabolic and inflammatory balance.

From this perspective, circadian disruption is not simply a scheduling inconvenience. It is a disorder of transcriptional timing, mediated through epigenetic changes in chromatin that determine how and when genes are used.

Once gene expression is viewed through this lens, the critical issue is no longer whether circadian rhythms are disrupted, but which gene programs lose their temporal organization when they are.

Circadian regulation does not act in isolated genes. It coordinated entire transcriptional programs: metabolic, inflammatory, mitochondrial, and repair pathways. These are intended to operate sequentially throughout the day. Epigenetic control of chromatin ensures that these programs are activated only when the cellular and systemic environment is prepared to support them.

In practical terms, circadian timing schedules gene expression across the day. Genes involved in glucose uptake, insulin signaling, and lipid metabolism are preferentially expressed during the biological day, when nutrient availability and activity are expected.

Genes governing mitochondrial repair, antioxidant defense, and inflammatory restraint peak during the biological night, when energy demand is lower and cellular maintenance is prioritized. Health depends not only on whether these genes are expressed, but on whether they are expressed in the correct temporal context.

When circadian timing erodes, gene expression loses sequence, coherence, and metabolic efficiency, gradually reshaping physiology and disease risk.

Circadian control of metabolic gene programs

One of the best-characterized circadian transcriptional programs involves genes that regulate glucose metabolism, lipid handling, and insulin signaling. These genes are rhythmically expressed, with chromatin accessibility and transcriptional activity aligned to the biological day, when nutrient availability and energy demand are expected.

Epigenetic marks placed by circadian clock machinery help ensure that metabolic genes are accessible during periods of metabolic readiness. Histone acetylation and methylation at these sites exhibit daily oscillations, thereby reinforcing coordinated substrate utilization and metabolic flexibility.

When circadian timing is disrupted, this coordination breaks down. Metabolic genes may still be transcribed, but their expression occurs out of phase with hormonal signaling and mitochondrial capacity. The result is inefficient glucose handling, impaired lipid metabolism, and reduced insulin sensitivity, which are all patterns commonly observed in metabolic disease.

These changes do not require genetic mutations; they arise from epigenetically mediated shifts in gene-expression timing, accumulated through repeated circadian misalignment.

Which genes are expressed and when?

Rather than thinking about circadian rhythms globally, it is more useful to think in terms of gene programs that are scheduled over time.

» Mitochondrial and redox gene programs (activity-rest transition). Genes controlling oxidative phosphorylation, mitochondrial biogenesis, and antioxidant defense are also rhythmically expressed, with timing designed to balance energy production and oxidative stress. Under normal conditions:

• genes supporting energy production rise alongside activity

• genes governing reactive oxygen species (ROS) detoxification peak in coordination

• mitochondrial repair and turnover occur during relative rest

Epigenetic regulation ensures that chromatin accessibility at these genes follows this rhythm. When circadian regulation is disrupted, the amplitude of mitochondrial gene expression flattens. Genes are still expressed, but without proper timing. ROS production may no longer be matched by antioxidant capacity, leading to chronic oxidative stress.

Clinically, this manifests as fatigue, reduced stress tolerance, impaired recovery, and metabolic inflexibility; patterns which are frequently observed in chronic disease without primary mitochondrial pathology.

» Inflammatory and immune gene programs (biological night). Inflammatory signaling is also circadian-regulated. Genes involved in cytokine production, immune cell trafficking, and inflammasome activity are normally temporally restrained, with peak activity occurring when tissue repair and immune surveillance are most adaptive.

When circadian timing is disrupted, this restraint weakens. Inflammatory genes remain partially active across the day, contributing to persistent low-grade inflammation rather than acute, resolved immune responses.

A note on BMAL1: Located on chromosome 11p15.3, BMAL1 is indispensable for circadian rhythm generation and systemic metabolic coordination. Human polymorphisms in BMAL1 are associated with hypertension, T2DM, myocardial infarction, seasonal affective disorder, and bipolar disorder, highlighting its wide-ranging physiological effects.

Variants such as rs12363415 and rs2279287 have been associated with abnormal blood pressure regulation, impaired glucose homeostasis, and cardiometabolic risk, underscoring the pleiotropic effects of this core clock gene on human health.

Clinically, BMAL1 functions as a central regulator of cardiometabolic processes in humans. BMAL1 variants are associated with abnormal blood pressure regulation and impaired glucose homeostasis in patients with myocardial infarction.

Chrono-epigenetic drift and long-term disease

With repeated circadian disruption through irregular light exposure, feeding at biologically inappropriate times, or chronic rhythm instability, epigenetic regulation becomes progressively less precise. Histone markers lose their rhythmicity, and chromatin accessibility becomes less temporally defined, reducing the amplitude and precision of circadian gene expression.

This process, often described as chrono-epigenetic drift, scrambles the timing of our genes. Over years, this contributes to:

• reduced metabolic resilience

• mitochondrial inefficiency

• chronic inflammation

• increase susceptibility to cardiometabolic and neurodegenerative disease

From this perspective, chronic disease emerges from a combination of genetic risk, environmental exposure, and persistent mistiming of gene expression.

In conclusion

Circadian rhythms matter not simply because they influence sleep, but because they govern the timing of gene expression across metabolic, mitochondrial, and inflammatory systems. Through epigenetic control of chromatin, biological timing determines which genes are accessible, when they are transcribed, and whether physiological processes remain coordinated or drift toward dysfunction.

From this perspective, chronic disease arises not only from the genes we carry or the pathways activated, but also from the gradual loss of temporal organization in gene expression itself. The most important question, then, is not how well we sleep but whether our genes are being expressed at the right time.

Grateful to Dr. Hunter for his insights and contributions to the thinking that shaped this piece.

Leave a comment

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

References

Fagiani, F., Di Marino, D., Romagnoli, A., Recchia, C., Lanni, C., & Govoni, S. (2022). Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduction and Targeted Therapy, 7(1), 41. https://doi.org/10.1038/s41392-022-00899-y

González-Suárez, M., & Aguilar-Arnal, L. (2024). Histone methylation: At the crossroad between circadian rhythms in transcription and metabolism. Frontiers in Genetics, 15, Article 1343030. https://doi.org/10.3389/fgene.2024.1343030

Mao, W., Ge, X., Chen, Q., & Li, J. D. (2025). Epigenetic mechanisms in the transcriptional regulation of circadian rhythm in mammals. Biology, 14(1), 42. https://doi.org/10.3390/biology14010042

Schrader, L. A., Ronnekleiv-Kelly, S. M., Hogenesch, J. B., Bradfield, C. A., & Malecki, K. M. (2024). Circadian disruption, clock genes, and metabolic health. Journal of Clinical Investigation, 134(14), Article e170998. https://doi.org/10.1172/JCI170998

Her, T. K., Li, J., Lin, H., Liu, D., Root, K. M., Regal, J. F., Alejandro, E. U., & Cao, R. (2024). Circadian disruption across lifespan impairs glucose homeostasis and insulin sensitivity in adult mice. Metabolites, 14(2), 126. https://doi.org/10.3390/metabo14020126

In Part I of this series, we outlined the physiology of the inflammatory reflex and its role as a closed-loop neuroimmune control system. In this second and final paper, we move from framework to intervention. Here, we examine how vagus nerve stimulation (VNS) and targeted lifestyle-based neuromodulation can be combined to restore regulatory control, reduce the inflammatory burden, support resolution, and address chronic disease at its upstream control point.

As vagus nerve stimulation devices have become widely available through consumer marketplaces, the concept of a ‘vagal reset’ has been increasingly promoted in wellness and social media spaces. It is crucial to distinguish informal wellness practices from clinical neuromodulation, which carries physiological effects, contraindications, and dose-dependent risks that warrant medical oversight.

When VNS is relevant

This regulatory model is most useful when symptoms suggest a breakdown in system-level coordination, rather than dysfunction isolated to a single organ. Clinically, this often presents with symptoms that span multiple domains, including fatigue, pain, cognitive impairment, gastrointestinal disturbance, sleep disruption, and orthostatic symptoms that fluctuate with stress, illness, exertion, or circadian disruption, rather than following a single anatomical or biochemical pathway.

These patients frequently demonstrate poor recovery after otherwise minor stressors or infections and show signs of chronic or relapsing inflammation that cannot be fully explained by one dominant disease process. In such cases, impaired autonomic and neuroimmune regulation offers a unifying framework for understanding symptom persistence and fragility.

Clinically, this regulatory approach is most effective when applied sequentially: first identifying patterns of impaired regulation, then reducing autonomic load, and finally layering neuromodulatory and conditioning inputs to restore physiological flexibility. This sequencing matters, as premature stimulation in the setting of unresolved autonomic stress often produces inconsistent or blunted responses.

How neuromodulation changes the inflammatory model

Under physiological conditions, inflammatory mediators released in peripheral tissues activate sensory (afferent) fibers of the vagus nerve. These afferent fibers do not merely transmit information passively; they function as a real-time surveillance system, continuously reporting immune activity to the brainstem.

Afferent vagal fibers project primarily to the nucleus tractus solitarius (NTS), a brainstem structure that serves as a central integration hub for visceral information. The NTS does not process immune signals in isolation. Instead, it integrates immune input with cardiovascular status, respiratory rhythm, metabolic state, circadian timing, and stress-related signals arriving from higher brain centers.

Once processed centrally, coordinated efferent vagal output restrains excessive immune activation, particularly through macrophage signaling. This does not result in immune suppression, but proportional inhibition, allowing inflammation to resolve rather than propagate.

The inflammatory reflex operates on a timescale of seconds, distinguishing neural regulation from endocrine or pharmacologic approaches and helping explain why cytokine blockade alone often fails to restore balance.

Measuring vagal regulatory failure

Before attempting to restore vagal regulation, clinicians must recognize when it is impaired. Heart rate variability (HRV) provides a practical, non-invasive window into this system.

HRV reflects variability between successive heartbeats, driven primarily by parasympathetic (vagal) modulation of cardiac rhythm. While measured at the heart, this modulation reflects broader vagal output affecting multiple systems, including immune regulation. Persistently reduced HRV suggests diminished inhibitory capacity, increasing vulnerability to prolonged inflammation, exaggerated stress responses, and impaired recovery.

Low HRV is commonly observed in conditions marked by fatigue, pain sensitization, orthostatic intolerance, and cognitive dysfunction, including fibromyalgia, Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), Postural Orthostatic Tachycardia Syndrome (POTS), inflammatory bowel disease, and long COVID. However, HRV is sensitive to sleep, circadian rhythm, infection, medications, alcohol, and psychological stress.

Importantly, HRV reflects vagal modulation at the level of the heart, but it is not a comprehensive measure of vagal function. Vagal dysregulation may also be evident through orthostatic intolerance, stress-sensitive gastrointestinal motility disturbances, impaired inflammatory resolution, or multisystem symptom clustering—even when resting HRV appears within normal ranges.

As with any clinical intervention, VNS should be paired with appropriate monitoring to assess response and guide continuation. Improvements are best evaluated through functional measures such as HRV trends, orthostatic tolerance, sleep quality, recovery time, and symptom patterns, rather than subjective sensation alone.

Interpreting heart rate variability in a clinical context

Taken together, these observations underscore the need to interpret HRV in context. HRV should be understood as an indicator of regulatory capacity rather than a direct measure of health, fitness, or disease. There is no universal HRV value that defines health; baseline values vary widely with age, sex, genetics, fitness level, medications, and individual autonomic architecture.

For orientation only, commonly reported Root Mean Square of Successive Differences (RMSSD, referring to a heart rate variability metric reflecting short-term, parasympathetic activity) values below ~20 ms are often seen in states of autonomic impairment or acute physiological load; 20–40 ms is typical under sustained stress or sedentary conditions; 40–70 ms is typical of individuals with adequate autonomic flexibility; and higher values are frequently observed in endurance-trained populations.

These ranges are not diagnostic, and higher is not inherently better. Health is defined by adaptability and recovery.

Clinically useful HRV assessment depends on consistency rather than precision. RMSSD is the most informative metric for vagal modulation and should be interpreted longitudinally under standardized conditions. Persistent suppression or loss of recovery following rest is more instructive than day-to-day fluctuation.

Invasive vs non-invasive stimulation

Implanted cervical VNS stimulates both afferent and efferent fibers directly and has demonstrated durable anti-inflammatory effects in refractory rheumatoid arthritis and Crohn’s disease. These outcomes suggest that repeated activation of vagal circuits can recalibrate immune set-points over time.

Non-invasive transcutaneous approaches primarily stimulate afferent fibers. This is not a limitation: afferent signaling is the gateway to central integration, which then coordinates downstream regulation across systems. However, effectiveness depends on sufficient intensity, appropriate targeting, and cumulative exposure.

Non-response is frequently attributable to subthreshold stimulation rather than to failure of the underlying model; studies demonstrating benefit typically employ frequencies in the 20–25 Hz range, with adequate pulse width and cumulative dosing.

While non-invasive VNS devices are readily accessible and relatively simple to use (a wearable clip on or near the ear or a handheld device pressed against the side of the neck), their quality, output, and targeting vary widely.

VNS is not for all individuals, and caution must be taken for individuals with implanted electronic devices, cardiac abnormalities, specific medication profiles, and those who are pregnant.

A qualified medical or clinical practitioner should guide the use of these devices to ensure appropriate selection, parameter settings, and patient suitability, as subtherapeutic or poorly targeted stimulation may lead to false assumptions about efficacy.

Moving beyond cytokines to support inflammatory resolution

Early VNS studies focused on reductions in TNF-α and IL-6 as markers of success. While important, cytokines represent only one phase of inflammation. Recovery requires resolution: the active termination of immune responses and initiation of tissue repair.

Preclinical research suggests that vagus nerve stimulation influences inflammation not only by reducing cytokine output, but by actively supporting the body’s ability to shut an inflammatory response down once it has served its purpose. One mechanism by which this occurs is accelerated clearance of neutrophils, the short-lived immune cells that are the first to arrive at sites of tissue injury or infection.

When neutrophils remain in tissue longer than necessary, they perpetuate local damage and ongoing immune activation. VNS appears to shorten this phase by promoting the timely removal.

VNS also influences lipid mediator pathways that generate specialized pro-resolving mediators (SPMs). These molecules act as biological stop signals, instructing immune cells to disengage, regulate residual inflammation, and restore tissue integrity. Clinically, impaired resolution helps explain prolonged flares, delayed recovery, and cumulative symptom burden even when inflammatory markers appear modest.

VNS alone is not sufficient

Neural circuits do not operate in isolation. Their responsiveness depends on neurotransmitter availability, membrane composition, afferent signal quality, and central integration. For this reason, lifestyle inputs are best understood as external neuromodulators rather than wellness strategies.

Slow, controlled breathing alters intrathoracic pressure, directly stimulating vagal afferents linked to baroreceptor and cardiopulmonary feedback. These signals converse in the NTS, reinforcing parasympathetic dominance and improving autonomic flexibility. While breathing practices do not directly suppress cytokines, they improve the signal environment within which immune regulation occurs.

Acute cold exposure activates reflexive parasympathetic responses, including the diving reflex, which increases vagal output and suppresses sympathetic tone. Although clinical trials directly linking cold exposure to inflammatory reflex engagement are limited, the underlying neural pathways overlap substantially with those targeted by VNS.

Vagal tone follows circadian rhythms. Sleep disruption fragments autonomic regulation, sustaining sympathetic dominance and impairing immune restraint. Restoring consistent sleep timing improves the nervous system’s ability to interpret and respond appropriately to immune signals.

Nutrition as a determinant of regulatory capacity

Omega-3 fatty acids serve as substrates for the production of specialized pro-resolving mediators (SPMs). This class of lipid-derived signaling molecules actively coordinates the resolution phase of inflammation.

Dietary patterns that support inflammatory resolution, such as those rich in omega-3 fatty acids, polyphenols, and fermentable fibers, may enhance downstream responsiveness once regulatory signaling is restored, without acting as primary drivers themselves. Excess alcohol intake, irregular meal timing, and chronic stimulant use can increase autonomic noise and blunt neuromodulatory effects, particularly in patients with already reduced regulatory reserve.

In clinical practice, dysbiosis, increased intestinal permeability, or persistent low-grade gut inflammation can introduce excessive afferent ‘noise,’ blurring signal clarity to the brainstem, and reducing responsiveness to vagus nerve stimulation or other regulatory interventions.

Addressing gut-related contributors such as meal timing, fermentable substrate load, and inflammatory burden does not substitute for neuromodulation. Still, it can materially improve the fidelity of afferent signaling and the consistency of downstream regulation.

Acetylcholine is the effector neurotransmitter of vagal immune restraint. Adequate choline intake ensures substrate availability but does not override neural control. Practically, this means nutrition supports capacity; regulation still depends on circuit engagement.

Clinical synthesis

In practice, this framework is most useful when applied sequentially: first, identifying patterns of impaired regulation; then, reducing autonomic load; and finally, layering neuromodulatory and conditioning inputs to restore flexibility. VNS and lifestyle-based neuromodulation are complementary approaches alongside standard care. They address the regulatory layer that determines whether inflammation resolves or persists.

The shift from suppression to regulation does not eliminate the need for disease-specific treatment. It restores the system that governs proportion, timing, and recovery. For practitioners managing chronic, relapsing, or multisystem inflammatory conditions, this regulatory lens offers a coherent approach to upstream intervention, where control, rather than containment, becomes possible.

For these reasons, vagus nerve stimulation should be used as a clinical tool, applied deliberately, monitored over time, and integrated into broader care, rather than as a standalone or unsupervised self-experiment.

In conclusion

For many practitioners, chronic inflammation presents not as a single disease to be treated, but as a pattern of fragility: patients who relapse easily, recover slowly, and accumulate symptoms across systems despite appropriate disease-specific care. What unites these presentations is impaired physiological regulation.

The framework outlined here provides a means of identifying and addressing coordination failures. Vagal regulation does not replace immunology, rheumatology, or pharmacology; it determines how effectively those systems are integrated, restrained, and resolved. When inhibitory control is intact, inflammatory responses remain proportional and time-limited.

When compromised, even modest stressors such as illness, exertion, and sleep disruption can trigger prolonged or cascading effects.

Clinically, this shifts the task from suppressing signals to restoring control. It encourages practitioners to look beyond isolated biomarkers or organ systems and instead assess adaptability, recovery, and coherence across domains. Heart rate variability, orthostatic responses, gastrointestinal function, sleep patterns, and symptom fluctuation are not merely ancillary observations but clues to regulatory capacity.

Neuromodulation, whether delivered through vagus nerve stimulation or conditioned through behavioral and lifestyle inputs, is most effective when applied within a physiological context that supports signal clarity and responsiveness. Reducing autonomic load, stabilizing circadian rhythms, and supporting resolution biology do not compete with stimulation; they determine whether it works.

In moving from suppression to regulation, the goal is not to do more but to enable the body to complete what it has already begun: an appropriate response, followed by resolution.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

Disclaimer

This article is written for clinicians and scientific readers. It provides evidence-based information on vagus nerve stimulation and related concepts for educational purposes only. This does not constitute medical advice, diagnosis, treatment recommendations, or a substitute for professional healthcare guidance. Consult qualified healthcare providers for individual patient care purposes. No doctor-patient relationship was established by reading this content.

References

Austelle, C. W., O’Leary, G. H., Thompson, S., & Badran, B. W. (2024). Vagus nerve stimulation (VNS): Recent advances and future directions. Clinical Autonomic Research, 34, 529–547. https://doi.org/10.1007/s10286-024-01065-w

Badran, B. W., Yu, A. B., Adair, D., Mappin, G., DeVries, W. H., Jenkins, D. D., George, M. S., & Bikson, M. (2019). Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): Technique, targeting, and considerations. Journal of Visualized Experiments, (143), Article e58984. https://doi.org/10.3791/58984

Besson, C., Baggish, A. L., Monteventi, P., Schmitt, L., Stucky, F., Gremeaux, V., & Noirez, P. (2025). Assessing the clinical reliability of short-term heart rate variability: Insights from controlled dual-environment and dual-position measurements. Scientific Reports, 15(1), Article 5611. https://doi.org/10.1038/s41598-025-89892-3

Chen, Z., & Liu, K. (2025). Mechanisms and applications of vagus nerve stimulation. Current Issues in Molecular Biology, 47, Article 122. https://doi.org/10.3390/cimb47020122

Drewes, A. M., Brock, C., Rasmussen, S. E., Møller, H. J., Brock, B., Deleuran, B. W., & Farmer, A. D. (2021). Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: Results of a pilot study. Scandinavian Journal of Rheumatology, 50(1), 20–27. https://doi.org/10.1080/03009742.2020.1764617

Falvey, A. (2022). Vagus nerve stimulation and inflammation: Expanding the scope beyond cytokines. Bioelectronic Medicine, 8(1), Article 19. https://doi.org/10.1186/s42234-022-00100-3

Johnson, R. L., & Wilson, C. G. (2018). A review of vagus nerve stimulation as a therapeutic intervention. Journal of Inflammation Research, 11, 203–213. https://doi.org/10.2147/JIR.S163248

Kim, A. Y., Marduy, A., de Melo, P. S., et al. (2022). Safety of transcutaneous auricular vagus nerve stimulation (taVNS): A systematic review and meta-analysis. Scientific Reports, 12, Article 22055. https://doi.org/10.1038/s41598-022-25864-1

Lange, G., Janal, M. N., Maniker, A., Fitzgibbons, J., Fobler, M., Cook, D., & Natelson, B. H. (2011). Safety and efficacy of vagus nerve stimulation in fibromyalgia: A phase I/II proof-of-concept trial. Pain Medicine, 12(9), 1406–1413. https://doi.org/10.1111/j.1526-4637.2011.01203.x

Ma, L., Wang, H.-B., & Hashimoto, K. (2025). The vagus nerve: An old but new player in brain–body communication. Brain, Behavior, and Immunity, 124, 28–39. https://doi.org/10.1016/j.bbi.2024.11.023

Matsuoka, M., Yamaguchi, T., & Fujiwara, T. (2025). Transcutaneous auricular vagus nerve stimulation in healthy individuals, stroke, and Parkinson’s disease: A narrative review of safety, parameters, and efficacy. Frontiers in Physiology, 16, Article 1693907. https://doi.org/10.3389/fphys.2025.1693907

Tesser, J. R. P., Crowley, A. R., Box, E. J., et al. (2025). Vagus nerve–mediated neuroimmune modulation for rheumatoid arthritis: A pivotal randomized controlled trial. Nature Medicine. Advance online publication. https://doi.org/10.1038/s41591-025-04114-7

Veldman, F., Hawinkels, K., & Keszthelyi, D. (2025). Efficacy of vagus nerve stimulation in gastrointestinal disorders: A systematic review. Gastroenterology Report, 13, Article goaf009. https://doi.org/10.1093/gastro/goaf009

Zheng, Z. S., Simonian, N., Wang, J., & Rosario, E. R. (2024). Transcutaneous vagus nerve stimulation improves long COVID symptoms in a female cohort: A pilot study. Frontiers in Neurology, 15, Article 1393371. https://doi.org/10.3389/fneur.2024.1393371

In parallel, over the past 20 years, a different understanding has taken shape, one that reframes inflammation not as a standalone immune malfunction but as a regulatory problem. Landmark work by Kevin J. Tracey and colleagues demonstrated that inflammatory activity is under direct neural control. A seminal 2000 study also showed that electrical stimulation of the vagus nerve rapidly suppressed systemic tumor necrosis factor (TNF) release in the presence of endotoxins in the bloodstream. This study established the existence of a hardwired neural circuit (the inflammatory reflex) that can restrain immune activity in real time.

What initially appeared as a novel experimental finding has since evolved into a broader neuro-immune framework. Subsequent studies have extended this model beyond acute endotoxin exposure, demonstrating that vagus-mediated signaling can modify inflammatory tone across chronic disease states, aging, and metabolic dysfunction. More recent work has mapped specific brainstem nuclei and vagal pathways that mediate sensing of peripheral immune signals and coordinate rapid anti-inflammatory responses.

Neuro-immune paradigm shift

Within the traditional immunology framework, the immune system was viewed as largely autonomous, with the brain responding only secondarily through sickness behavior or endocrine stress pathways. Tracey’s work overturned this view by revealing a bidirectional neuro-immune dialogue. Immune cells signal the brain through direct neural signals carried by vagal afferent nerves. In response, the brain deploys rapid and targeted efferent signals that suppress inflammatory output at its source.

Crucially, the inflammatory reflex operates on the scale of seconds. Unlike hormonal responses, which unfold over minutes to hours, vagal efferent signaling can inhibit TNF, IL-1β, and IL-6 almost immediately. This speed and specificity laid the groundwork for the emerging field of bioelectronic medicine, which seeks to modulate disease by targeting neural circuits rather than indiscriminately blocking molecular pathways.

Failure of this reflex is increasingly implicated in inflammaging: the age-related accumulation of unresolved inflammation that accelerates cardiovascular disease, neurodegeneration, sarcopenia, and frailty. Vagus nerve stimulation (VNS) emerges from this model not as a workaround but as a logical strategy: rather than blocking inflammatory molecules after they are released, VNS aims to re-engage the neural circuits that usually keep immune responses proportional, time-limited, and self-resolving.

The inflammatory reflex as a control system

The inflammatory reflex functions as a closed-loop control system, analogous to other physiological regulatory circuits such as baroreflex control of blood pressure or glucose regulation. Like these systems, it consists of three essential components: signal detection, central integration, and effector response.

Peripheral immune activation generates cytokines and inflammatory mediators that are detected not only by immune receptors but also by sensory pathways of the vagus nerve. Afferent vagal fibers relay this information to brainstem nuclei, where immune signals are integrated with physiological context, including metabolic state, circadian cues, and psychological stress.

When inflammatory activity exceeds an appropriate threshold, efferent vagal output is engaged. Through downstream signaling pathways, including cholinergic modulation of macrophage activity, pro-inflammatory cytokine production is rapidly restrained. This inhibitory feedback limits the magnitude and duration of immune activation, allowing inflammation to resolve once the initiating threat has passed.

Chronic inflammation emerges when this regulatory loop is impaired. Reduced vagal tone blunts inhibitory signaling, lowering the threshold for immune activation and delaying termination of the inflammatory response. The result is not excessive immune reactivity per se, but loss of effective restraint; a failure of resolution rather than an overreaction.

Chronic disease, as a failed neural regulation

Reduced vagal tone is a consistent feature of a broad spectrum of chronic diseases, including rheumatoid arthritis, inflammatory bowel disease, metabolic syndrome, atherosclerosis, depression, and neurodegenerative disorders. Although these conditions differ clinically, they share a common biological signature: persistent low-grade inflammation coupled with impaired resolution.

The inflammatory reflex offers a unifying framework. Rather than viewing each disorder as an independent pathology driven by disease-specific triggers, they can be understood as manifestations of shared failure of neural regulation. When vagal inhibitory control is compromised, immune responses become exaggerated, prolonged, and self-perpetuating, driving tissue damage, metabolic dysfunction, and neuroimmune sensitization.

From this perspective, chronic inflammatory diseases are less a problem of immune excess and more a problem of regulatory failure. The nervous system, via the vagus nerve, emerges as a central coordinator of immune homeostasis, the decline of which with stress and aging may be a key driver of modern chronic disease. It also helps explain why chronic diseases often cluster within individuals and why interventions that improve overall physiological resilience, such as physical activity, sleep optimization, stress reduction, and metabolic health, exert broad anti-inflammatory effects across multiple organ systems.

The inflammatory reflex is an immunity regulator

Experimental and clinical evidence consistently support the inflammatory reflex as the core regulator of immune activity. In animal models, vagus nerve stimulation suppresses the release of inflammatory cytokines in diverse conditions, including sepsis, arthritis, colitis, and post-operative inflammation. These effects are rapid and reproducible, supporting the conclusion that they reflect a defined neural circuit.

Human data are closely aligned with these findings. Higher vagal tone, most commonly assessed by high-frequency heart rate variability (HRV), is inversely associated with circulating inflammatory markers, including IL-6, TNF-α, and C-reactive protein.

Individuals with higher HRV demonstrate a lower baseline inflammatory burden, faster resolution following immune challenge, and greater physiological adaptability to stress. Conversely, reduced vagal tone predicts increased inflammatory activity and poorer outcomes in multiple disease states.

Clinical trials have translated these observations into therapeutic concepts. In patients with rheumatoid arthritis, implanted vagus nerve stimulators reduce disease activity scores and cytokine production in those resistant to conventional therapy.

Similar benefits have been observed in patients with Crohn’s disease, with improvements in inflammatory markers and clinical symptoms. Importantly, these interventions were well tolerated, with minimal side effects and no evidence of global immunosuppression.

This is where vagus nerve stimulation differs fundamentally from pharmacologic anti-inflammatory approaches, and most drugs act by blocking specific cytokines or by suppressing immune cell activity more broadly. VNS, by contrast, modulates an upstream control system. It does not target a single molecule, but an entire regulatory circuit. This allows inflammation to be dynamically tuned rather than shut down indiscriminately, thereby reducing the risk of infection or immune rebound.

Taken together, these findings suggest that vagal tone functions not only as a biomarker but also as a systems-level regulator of the inflammatory set-point. The inflammatory reflex integrates immune activity with the metabolic state, circadian rhythms, psychological stress, and cardiorespiratory fitness.

Factors such as chronic stress, sleep disruption, sedentary behavior, insulin resistance, and aging converge on a shared pathway: suppression of vagal signaling and loss of inhibitory immune control.

What exactly is the vagus nerve?

Also called ‘cranial nerve X’, the vagus nerve derives its name from the Latin word vagus, which means ‘wandering,’ an apt description of its extensive anatomical reach. Originating in the brainstem, it descends through the neck and thorax to innervate the heart, lungs, liver, pancreas, and gastrointestinal tract, making it the body’s primary parasympathetic nerve.

Functionally, it is predominantly sensory, and 80-90% of its fibers carry information from peripheral organs back to the brain. These sensory signals are transmitted to the brainstem and then distributed to autonomic and higher regulatory centers involved in physiological and emotional control. The remaining 10-20% of fibers carry outgoing parasympathetic signals that coordinate heart rate, gastrointestinal function, and immune regulation.

The vagus nerve is composed of multiple fiber types. Unmyelinated C-fibers are exceptionally responsive to inflammatory signals, while myelinated A- and B-fibers support faster reflexes, such as cardiovascular control. This mixed architecture enables the vagus nerve to function, sampling internal conditions and adjusting physiological responses in real time.

How vagal nerve stimulation works

Vagus nerve stimulation does not add a foreign signal to the body. It amplifies and restores an existing signal. By increasing vagal efferent output, stimulation strengthens the timing and intensity of the brain’s inhibitory messages to immune cells, particularly innate immune cells such as macrophages. Functionally, this means inflammatory responses are shortened rather than suppressed.

Cytokine release is reduced when it becomes excessive, whereas antimicrobial functions, such as pathogen clearance, remain intact. Instead of forcing the immune system into silence, stimulation helps re-establish its ability to escalate when needed, and stand down when the threat has passed.

Vagus nerve and communication

Around 90% of vagal fibers innervate the gut. The gastrointestinal tract is the body’s largest immune interface, containing the majority of immune cells and the densest microbial ecosystem. Unsurprisingly, it is also a significant source of inflammatory signals that communicate with the brain via the vagus nerve.

Vagal sensory neurons do not directly ‘touch’ what is inside the gut. Instead, it relies on messenger cells within the intestinal lining to inform it what is occurring. Specialized gut cells called enteroendocrine cells (EECs) act like biological sensors and translators. They can detect nutrients and chemical by-products made by gut microbes, even though microbes themselves never contact nerve endings.

When certain gut bacteria break down the amino acid tryptophan, they produce compounds that trigger Trpa1 receptors on these EECs. This activation causes cells to release serotonin (5-HT) rapidly. Serotonin then stimulates nearby enteric motor neurons and transmits signals via the vagus nerve to the brain. In this way, the gut microbiome can rapidly communicate with the brain indirectly via EECs.

Stress, permeability, and inflammatory looping

The vagus nerve continuously monitors gastrointestinal activity. When the gut barrier weakens or the microbiome becomes imbalanced, immune cells release inflammatory signals, and microbial by-products leak through the intestinal lining. These signals are picked up by the vagus nerve and relayed to the brain. Under normal conditions, the brain responds by sending calming signals back down the vagus nerve.

These signals instruct immune cells, particularly macrophages, to suppress inflammation and initiate repair. This is how the body prevents a short-term immune response from becoming chronic.

Chronic stress disrupts this balance. Stress hormones increase gut permeability and enhance immune reactivity as more microbial products enter the tissue and inflammation rises, thereby further stimulating the stress response. Over time, this creates a self-reinforcing cycle: stress weakens the gut, the gut fuels inflammation, and inflammation keeps the nervous system in a state of high alert.

Macrophages can either promote inflammation or help resolve it. Signals from the vagus nerve act like switch, nudging these cells away from attack mode and toward healing. When vagal tone is low, as is common in chronic stress, metabolic dysfunction, and inflammatory disease, that switch doesn’t flip effectively. Inflammation stays ‘on’ longer than it should.

This calming signal does not shut down the immune system. It selectively reduces excessive inflammatory signaling while preserving the body’s ability to fight infection. In other words, it restores control versus suppression. When this neural braking system fails, inflammation does not fully resolve. What starts as a transient gastrointestinal disturbance can gradually escalate into widespread, low-grade inflammation throughout the body.

This helps explain why chronic inflammatory conditions often show up alongside gut symptoms, stress sensitivity, fatigue, and autonomic imbalance; not as separate issues, but as part of the same broken feedback loop.

The vagus nerve as a volume dial

VNS can be delivered invasively via implanted devices or noninvasively via transcutaneous approaches, but all methods share the same goal: restoring effective neural braking of inflammation.

What makes this gut-brain-immune system especially powerful is its precision. Most anti-inflammatory drugs work like a blanket. They can quiet inflammation, but they do so by broadly suppressing the immune system, which can leave the body more vulnerable to infection. The vagus nerve works differently. It acts more like a volume dial than an off switch.

When inflammation begins to spiral under chronic stress, gut permeability, or dysbiosis, the vagus nerve selectively targets harmful immune signals. It turns down excessive cytokine release without shutting down the immune system’s core defenses. Macrophages can still do their job, continuing to recognize, engulf, and clear bacteria and damaged cells.

An overly active immune system rarely causes chronic disease. It is caused by one that stays activated for too long. The vagus nerve helps restore the response to balance once the threat has passed, preventing inflammation from progressing to ongoing tissue damage.

When this neural ‘brake’ is working well, the body can mount a strong defense and then stand down efficiently. When vagal tone is low, inflammation loses its stop signal. The immune response lingers, spills beyond the gut, and contributes to fatigue, pain, metabolic dysfunction, and mood changes.

Together, this reframes inflammation as something to regulate. The goal is to restore the body’s ability to respond, resolve, and recover.

In conclusion

Chronic inflammation is rarely the result of an immune system that is too strong. More often, it reflects an immune response that has lost its ability to stand down. The evidence reviewed here supports a shift away from viewing inflammation solely as a biochemical cascade to be suppressed and toward understanding it as a regulated physiological process that depends on intact neural control.

The inflammatory reflex provides a coherent framework for this shift. Situating immune activity within a closed-loop neuroimmune control system helps explain why chronic inflammatory diseases cluster, why psychological stress and metabolic dysfunction so reliably worsen the inflammatory burden, and why resolution often fails despite aggressive molecular blockade. In this context, reduced vagal tone is not merely a correlate of disease severity but a plausible upstream driver of impaired inflammatory restraint.

This reframing has important clinical implications. If chronic inflammation reflects a failure of neural regulation rather than immune excess, then strategies that restore inhibitory control become central rather than adjunctive. Interventions that improve vagal tone, whether through physiological conditioning, behavioral inputs, or direct immunomodulation, are not alternative approaches to managing inflammation. They target the regulatory architecture that governs immune proportionality and resolution.

Understanding inflammation through this regulatory lens does not diminish the value of pharmacological therapies. Instead, it clarifies their limitations. Blocking cytokines after release may reduce symptoms, but it does not restore the system that determines when immune responses begin, how intensely they proceed, or when they end. Restoring that system requires engaging the neural circuits that evolved to coordinate immune activity with the broader physiological state.

From framework to intervention

Join us for Part II, where we will focus on VNS as a direct clinical application of this regulatory model. Building on the physiology outlined here, it examines how targeted neuromodulation can re-engage the inflammatory reflex, restore inhibitory control, and reduce inflammatory burden without global immunosuppression.

We will examine the current clinical evidence for VNS across inflammatory and immune-mediated conditions, compare invasive and non-invasive approaches, and examine how neuromodulation fits within a broader strategy that includes lifestyle interventions known to influence vagal tone. Together, these approaches point toward a more precise and physiologically aligned way of managing chronic inflammation; one that prioritizes regulation, resolution, and resilience over suppression alone.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Ahmed, U., Chang, Y. C., Zafeiropoulos, S., Nassrallah, Z., Miller, L., & Zanos, S. (2022). Strategies for precision vagus neuromodulation. Bioelectronic Medicine, 8(1), Article 9. https://doi.org/10.1186/s42234-022-00091-1

Badran, B. W., & Austelle, C. W. (2022). The future is noninvasive: A brief review of the evolution and clinical utility of vagus nerve stimulation. Focus, 20(1), 3–7. https://doi.org/10.1176/appi.focus.20210023

Báez-Pagán, C. A., Delgado-Vélez, M., & Lasalde-Dominicci, J. A. (2015). Activation of the macrophage α7 nicotinic acetylcholine receptor and control of inflammation. Journal of Neuroimmune Pharmacology, 10(3), 468–476. https://doi.org/10.1007/s11481-015-9601-5

Bellocchi, C., Carandina, A., Montinaro, B., Targetti, E., Furlan, L., Rodrigues, G. D., Tobaldini, E., & Montano, N. (2022). The interplay between autonomic nervous system and inflammation across systemic autoimmune diseases. International Journal of Molecular Sciences, 23(5), Article 2449. https://doi.org/10.3390/ijms23052449

Bonaz, B., Sinniger, V., Hoffmann, D., Clarencon, D., Mathieu, N., Dantzer, C., & Pellissier, S. (2016). Chronic vagus nerve stimulation in Crohn’s disease: A 6-month follow-up pilot study. Neurogastroenterology & Motility, 28(6), 948–953. https://doi.org/10.1111/nmo.12792

Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405(6785), 458–462. https://doi.org/10.1038/35013070

Caravaca, A. S., Gallina, A. L., Tarnawski, L., Shavva, V. S., Colas, R. A., Dalli, J., Malin, S. G., Hult, H., Arnardottir, H., & Olofsson, P. S. (2022). Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunit. Proceedings of the National Academy of Sciences, 119(22), Article e2023285119. https://doi.org/10.1073/pnas.2023285119

Cooper, T. M., McKinley, P. S., Seeman, T. E., Choo, T. H., Lee, S., & Sloan, R. P. (2015). Heart rate variability predicts levels of inflammatory markers: Evidence for the vagal anti-inflammatory pathway. Brain, Behavior, and Immunity, 49, 94–100. https://doi.org/10.1016/j.bbi.2014.12.017

D’Haens, G., Eberhardson, M., Cabrijan, Z., Danese, S., van den Berg, R., Löwenberg, M., Fiorino, G., Schuurman, P. R., Lind, G., Almqvist, P., Olofsson, P. S., Tracey, K. J., Hanauer, S. B., Zitnik, R., Chernoff, D., & Levine, Y. A. (2023). Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn’s disease patients: A prospective open-label study. Journal of Crohn’s and Colitis, 17(12), 1897–1909. https://doi.org/10.1093/ecco-jcc/jjad151

Falvey, A. (2022). Vagus nerve stimulation and inflammation: Expanding the scope beyond cytokines. Bioelectronic Medicine, 8(1), Article 19. https://doi.org/10.1186/s42234-022-00100-3

Falvey, A., Metz, C. N., Tracey, K. J., & Pavlov, V. A. (2022). Peripheral nerve stimulation and immunity: The expanding opportunities for providing mechanistic insight and therapeutic intervention. International Immunology, 34(2), 107–118. https://doi.org/10.1093/intimm/dxab068

Huston, J. M., & Tracey, K. J. (2011). The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. Journal of Internal Medicine, 269(1), 45–53. https://doi.org/10.1111/j.1365-2796.2010.02321.x

Kelly, M. J., Breathnach, C., Tracey, K. J., & Donnelly, S. C. (2022). Manipulation of the inflammatory reflex as a therapeutic strategy. Cell Reports Medicine, 3(7), Article 100696. https://doi.org/10.1016/j.xcrm.2022.100696

Koopman, F. A., Chavan, S. S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P. R., Mehta, A. D., Levine, Y. A., Faltys, M., Zitnik, R., Tracey, K. J., & Tak, P. P. (2016). Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proceedings of the National Academy of Sciences, 113(29), 8284–8289. https://doi.org/10.1073/pnas.1605635113

Ma, L., Wang, H.-B., & Hashimoto, K. (2025). The vagus nerve: An old but new player in brain–body communication. Brain, Behavior, and Immunity, 124, 111–114. https://doi.org/10.1016/j.bbi.2024.11.023

Mills, C. D. (2015). Anatomy of a discovery: M1 and M2 macrophages. Frontiers in Immunology, 6, Article 212. https://doi.org/10.3389/fimmu.2015.00212

Pavlov, V. A., & Tracey, K. J. (2012). The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nature Reviews Endocrinology, 8(12), 743–754. https://doi.org/10.1038/nrendo.2012.189

Pavlov, V. A., & Tracey, K. J. (2022). Bioelectronic medicine: Preclinical insights and clinical advances. Neuron, 110(21), 3627–3644. https://doi.org/10.1016/j.neuron.2022.09.003

Sohn, R., & Jenei-Lanzl, Z. (2023). Role of the sympathetic nervous system in mild chronic inflammatory diseases: Focus on osteoarthritis. Neuroimmunomodulation, 30(1), 143–166. https://doi.org/10.1159/000531798

Tracey, K. J. (2002). The inflammatory reflex. Nature, 420(6917), 853–859. https://doi.org/10.1038/nature01321

Tracey, K. J. (2007). Physiology and immunology of the cholinergic antiinflammatory pathway. Journal of Clinical Investigation, 117(2), 289–296. https://doi.org/10.1172/JCI30555

Veldman, F., Hawinkels, K., & Keszthelyi, D. (2025). Efficacy of vagus nerve stimulation in gastrointestinal disorders: A systematic review. Gastroenterology Report, 13, Article goaf009. https://doi.org/10.1093/gastro/goaf009

Ye, L., Bae, M., Cassilly, C. D., Jabba, S. V., Thorpe, D. W., Martin, A. M., Lu, H. Y., Wang, J., Thompson, J. D., Lickwar, C. R., Poss, K. D., Keating, D. J., Jordt, S. E., Clardy, J., Liddle, R. A., & Rawls, J. F. (2021). Enteroendocrine cells sense bacterial tryptophan catabolites to activate enteric and vagal neuronal pathways. Cell Host & Microbe, 29(2), 179–196. https://doi.org/10.1016/j.chom.2020.11.011

This framing is key when considering that an estimated 80% of conditions managed in primary care are lifestyle-related, including:

• Obesity

• Metabolic syndrome

• Hypertension

• Dyslipidemia

• Cardiovascular disease

• Type 2 diabetes

• Arthritis

• Osteoporosis

These conditions account for the majority of office visits, prescriptions, and long-term healthcare utilization. Yet they are commonly understood as inevitable consequences of aging, genetics, or bad luck, rather than as adaptive physiological responses to sustained environmental input.

What remains poorly understood by patients is that many of these diseases are not only preventable but also partially or fully reversible when addressed early and with sufficient therapeutic intensity. This is not a fringe assertion or a wellness ideology. It is the central premise of lifestyle medicine.

Defining Lifestyle Medicine

Lifestyle medicine is a clinical discipline that applies structured, evidence-based lifestyle interventions as a primary therapeutic modality for the prevention, treatment, and (in appropriate contexts) the remission of lifestyle-related chronic disease.

Unlike general health promotion or brief counseling, lifestyle medicine operates within a prescriptive medical framework. Interventions are selected, dosed, monitored, and adjusted based on disease severity, physiological response, and clinical risk.

The discipline focuses on six interrelated domains:

1. Nutrition

2. Physical activity

3. Sleep

4. Stress regulation

5. Substance abuse

6. Social connection

These are not addressed as isolated behaviors, but as interacting biological inputs that collectively influence metabolic signaling, inflammatory tone, endothelial function, hormonal regulation, immune activity, and gene expression.

A defining feature of lifestyle medicine is its emphasis on mechanism-based care. Rather than offering generic recommendations, clinicians translate disease physiology into actionable interventions, explicitly linking behavior change to measurable clinical outcomes. In this way, lifestyle modification is repositioned from an adjunctive recommendation to a therapeutic strategy with defined clinical intent.

How disease responds to lifestyle intervention

Lifestyle-related chronic diseases are modifiable because they arise from dynamic physiological processes rather than fixed pathology, and this is particularly true in the early and intermediate stages.

While genetic predisposition influences susceptibility, gene expression, metabolic function, and inflammatory signaling are profoundly shaped by environmental inputs, many of which are directly influenced by daily behavior.

Several shared mechanisms explain why diverse chronic diseases respond to lifestyle intervention:

1. Insulin resistance and metabolic dysfunction. Insulin resistance represents a central organizing feature of modern chronic disease. Excess caloric intake, poor diet quality, physical inactivity, sleep disruption, and chronic stress impair insulin signaling, leading to hyperinsulinemia, ectopic fat deposition, and altered cellular metabolism.

These changes precede and drive the development of type 2 diabetes, hypertension, dyslipidemia, cardiovascular disease, and metabolic syndrome. Lifestyle interventions that improve insulin sensitivity, such as increasing dietary fiber, reducing ultra-processed foods, restoring circadian alignment, and engaging in regular physical activity, can rapidly alter glycemic control and metabolic markers, often within weeks.

2. Chronic low-grade inflammation. Persistent low-grade inflammation is a unifying feature across cardiometabolic, musculoskeletal, and degenerative diseases. Adipose tissue dysfunction, gut barrier disruption, oxidative stress, and psychosocial stress contribute to sustained inflammatory signaling.

This inflammatory milieu accelerates atherosclerosis, joint degeneration, bone loss, and insulin resistance. Anti-inflammatory dietary patterns, consistent physical activity, stress regulation, and sleep optimization reduce pro-inflammatory cytokine activity and improve immune regulation, directly influencing disease trajectory.

3. Endothelial and vascular dysfunction. Endothelial health refers to the function of the endothelium, the thin layer of cells that lines the interior of blood vessels. These cells actively regulate vascular tone, blood pressure, and tissue perfusion by releasing signaling molecules (most notably nitric oxide), which tell blood vessels when to relax and improve blood flow. Healthy endothelial signaling supports efficient oxygen and nutrient delivery while protecting the vessel wall from inflammation and clot formation.

Over time, adverse lifestyle factors such as poor diet quality, physical inactivity, chronic stress, smoking, sleep disruption, and metabolic dysfunction impair nitric oxide signaling and increase oxidative stress.

This shifts the vascular environment toward inflammation, stiffness, and plaque formation, setting the stage for atherogenesis. Because endothelial dysfunction often develops long before overt cardiovascular disease appears, and remains highly responsive to lifestyle inputs, it represents an early, modifiable driver of long-term vascular risk.

4. Musculoskeletal and mitochondrial decline. Sedentary behavior and inadequate protein intake accelerate sarcopenia and bone loss, contributing to frailty, insulin resistance, and osteoporosis. Resistance training, adequate protein distribution, and mechanical loading stimulate osteoblastic and myogenic signaling, improving strength, metabolic health, and fracture risk even in older adults.

What ‘reversal’ means in the clinical context

The term “reversal” is often misunderstood and requires a careful clinical definition. In lifestyle medicine, reversal does not imply permanent immunity from disease, nor does it negate the influence of genetics or aging. Instead, reversal refers to sustained normalization or meaningful improvement of disease markers and function while therapeutic lifestyle interventions are maintained. Clinical reversal may include:

• Restoration of biomarkers below diagnostic thresholds

• Reduces disease activity and complication risk

• Decreased medication burden under appropriate medical supervision

• Improved functional capacity and quality of life

For example, individuals with type 2 diabetes may achieve normoglycemia without pharmacologic therapy; patients with hypertension may maintain blood pressure control without antihypertensives; and individuals with dyslipidemia may normalize lipid profiles through dietary and activity-based intervention.

Not all conditions reverse in the same way. Structural disease, such as advanced osteoarthritis or established osteoporosis, may not fully resolve. However, symptom burden, progression, fracture risk, and functional decline can often be meaningfully reduced.

Lifestyle medicine reframes success away from disease labels and toward physiological resilience and functional restoration. Reversal, therefore, is best understood as a clinical outcome rather than a cure. It reflects improved biology under sustained conditions, not the absence of vulnerability.

Delivering lifestyle medicine in a clinical setting

Lifestyle medicine is effective only when delivered at a therapeutic dose. Brief counseling or isolated recommendations rarely produce durable physiological change, particularly in advanced disease states. Effective delivery requires structure, intensity, and longitudinal support.

Intensive Therapeutic Lifestyle Change (ITLC) programs represent the most robust application of lifestyle medicine. These programs apply lifestyle interventions with a level of rigor comparable to pharmacologic treatment protocols. They typically include:

• Prescribed nutrition interventions with defined quality and composition targets

• Structured physical activity programs

• Sleep and circadian rhythm interventions

• Stress regulation practices

• Ongoing education focused on disease physiology

• Regular monitoring of clinical markers

ITLC programs allow patients to experience rapid, measurable improvement. This experiential shift alters patients’ understanding of what is biologically possible, increasing engagement and adherence during long-term maintenance.

The importance of clinical structure

Lifestyle medicine is not a self-directed process of assembling fragmented information from the internet. Without clinical context, patients are left to navigate conflicting advice, misapply interventions, or abandon change due to a lack of feedback. Structured programs provide prioritization, sequencing, and physiological rationale; elements necessary for therapeutic success.

Patients typically engage in a care model in which medical professionals diagnose and monitor disease status. In contrast, lifestyle medicine–trained clinicians and other health professionals provide education, implementation support, and accountability. This structure allows lifestyle medicine to function as first-line therapy while maintaining safety and clinical oversight.

Patient empowerment

A defining outcome of lifestyle medicine is patient empowerment, not as a philosophical ideal, but as a clinical necessity. Chronic disease management requires daily decisions that no healthcare system can make on a patient’s behalf. Lifestyle medicine equips patients with the physiological understanding needed to participate actively in their care. Empowerment in this context means:

• Understanding how daily inputs influence biomarkers and symptoms

• Using objective feedback to guide decision-making

• Developing skills to self-manage risk over time

• Transitioning from passive recipient to informed participant

Importantly, empowerment does not mean disengagement from medical care. Instead, it restores the patient to the center of a collaborative model, reducing reliance on escalating interventions while improving adherence when medical therapy is required.

In conclusion

The majority of chronic diseases treated in modern clinical practice are lifestyle-related, yet this reality remains poorly understood by the very patients most affected. Lifestyle medicine addresses this gap by targeting the biological mechanisms that underlie chronic disease, offering a pathway toward remission, functional restoration, and long-term resilience.

When delivered with sufficient intensity, structure, and clinical rigor, lifestyle medicine is not an alternative to medical care. It is a foundational component of effective chronic disease treatment. As healthcare systems continue to confront the rising burden of lifestyle-related illness, integrating lifestyle medicine as first-line therapy is not optional; it is clinically and biologically necessary.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

American College of Lifestyle Medicine. (2023). Lifestyle medicine core competencies.

https://lifestylemedicine.org

Bodai, B. I., Nakata, T. E., Wong, W. T., Clark, D. R., Lawenda, S., Tsou, C., … Campbell, T. M. (2018). Lifestyle medicine: A brief review of its dramatic impact on health and survival. The Permanente Journal, 22, 17–025. https://doi.org/10.7812/TPP/17-025

Egger, G., & Dixon, J. (2023). Beyond obesity and lifestyle medicine: A systems-based approach to chronic disease. American Journal of Lifestyle Medicine, 17(1), 3–12.

Katz, D. L., Frates, E. P., Bonnet, J. P., & Gupta, S. K. (2022). Lifestyle medicine as a pillar of modern healthcare. Progress in Cardiovascular Diseases, 70, 44–51.

Knowler, W. C., et al. (2022). Long-term effects of lifestyle intervention on cardiometabolic risk. The New England Journal of Medicine, 386(4), 399–409.

Ornish, D., et al. (2023). Intensive lifestyle changes and cardiovascular disease outcomes. Journal of the American College of Cardiology, 81(2), 121–134.

Taylor, R., et al. (2024). Type 2 diabetes remission: Mechanisms and clinical implications. Diabetes Care, 47(1), 10–19.

World Health Organization. (2023). Diet, nutrition, and the prevention of chronic diseases.

https://www.who.int

A Non-Alcoholic Fatty Liver Disease (NAFLD) diagnosis is becoming much more commonplace, and current estimates indicate around 30% (and rising) of the global population lives with it. Some experts believe the actual rate is even higher because most people have no symptoms and aren’t screened until something shows up on routine labs.

This makes NAFLD more common than type 2 diabetes, more common than cardiovascular disease, and far more common than most cancers.

The numbers are rising quickly because the metabolic landscape around us has changed: more ultra-processed foods, more sedentary lifestyles, higher and more chronic stress loads, disrupted sleep, environmental exposures, and a mismatch between how our biology evolved and how we now live.

The link between this landscape and our liver is why NAFLD was re-coined as MASLD (Metabolic-dysfunction Associated Steatotic Liver Disease). It is not simply a ‘liver problem’ in isolation. It is better understood as a whole-body metabolic imbalance that expresses itself in the liver. And the encouraging part is this: metabolic function is highly influenceable.

The information that follows is in no way a substitute for medical care.

To appreciate why MASLD forms, and more importantly, where we have leverage to influence it, we need to look at the physiology. Let’s outline the key metabolic processes involved, starting with lipid (fat) handling and mitochondrial function, inflammation, then the gut-liver axis. So many things come back to the gut!

Physiology and etiology of MASLD

MASLD develops when the liver receives more energy substrates than it can process or export. Liver cells will begin accumulating triglycerides from three main sources: dietary fat, free fatty acids (FFAs) released from insulin-resistant fat tissue, and de novo lipogenesis: the liver’s internal production of fat from excess carbohydrates (particularly fructose).

When insulin resistance develops systemically, fat tissue continues releasing fatty acids even in the ‘fed’ state. Skeletal muscle, which usually serves as the primary metabolic buffer, becomes less able to take up and oxidize glucose and fatty acids, redirecting excess substrates toward the liver. This nutrient overload sets the stage for a condition called steatosis.

Compounding the issue is chronic low-grade inflammation that occurs when dysfunctional fat tissue releases inflammatory cytokines. These cytokines interfere with insulin receptor signaling inside liver cells. When insulin signaling falters, the liver increases fat production and decreases fat oxidation, a combination that accelerates lipid accumulation.

Together, these processes create a metabolic loop: excess substrate delivery → impaired insulin signaling → increased fat storage → further insulin resistance.

Mitochondrial dysfunction as a central driver

Healthy mitochondria metabolize fatty acids through β-oxidation and generate energy through oxidative phosphorylation. In MASLD, the system becomes overloaded.

Mitochondria begin producing excess reactive oxygen species (ROS), unstable oxygen molecules that damage proteins, lipids, and mitochondrial DNA. Over time, mitochondria undergo structural changes, including increased mitochondrial fission, the stress-induced fragmentation of our mitochondrial network. When fission outpaces mitochondrial fusion and mitophagy (the removal of damaged mitochondria), dysfunctional mitochondria begin to accumulate.

This reduces the cell’s ability to oxidize incoming fatty acids, forcing more lipids into storage and increasing vulnerability to oxidative damage. Eventually, mitochondrial strain shifts from adaptive to pathological, acting as a major driver of the progression from simple steatosis to steatohepatitis and fibrosis.

Oxidative stress and liver cell injury

While simple triglyceride storage can be relatively inert, certain lipid species are directly toxic to hepatocytes. Ceramides, diacylglycerols, and other lipotoxic intermediates impair insulin receptor signaling, activate the cell’s emergency response system, and promote apoptosis. Polyunsaturated fatty acids can undergo peroxidation under oxidative conditions, generating reactive aldehydes that cross-link proteins and damage both mitochondrial and cellular membranes.

Cumulatively, these processes promote inflammatory cascades, alter nuclear gene expression, and contribute to fibrosis. Although not all MASLD cases progress to advanced disease, evidence suggests that liver cell injury begins early, driven by oxidative stress and mitochondrial imbalance. These lipotoxic pathways create an environment in which liver cells are increasingly vulnerable to further injury, impaired repair mechanisms, and metabolic deterioration.

Inflammation and immune activation

As oxidative and metabolic stress intensify, the liver’s immune system becomes increasingly engaged. Kupffer cells, the resident immune cells of the liver, detect danger-associated molecular patterns released from injured liver cells and respond by producing pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β.

These cytokines activate intracellular stress signaling pathways. These pathways further impair insulin signaling and reinforce mitochondrial stress, amplifying the metabolic spiral that drives MASLD progression. Persistent immune activation also influences stellate cell activation and fibrogenesis, establishing a link between metabolic dysregulation and structural liver injury.

Gut-liver axis and metabolic endotoxemia

Emerging evidence emphasizes the role of intestinal dysbiosis in the pathogenesis of MASLD. Alterations in gut microbial composition can increase intestinal permeability, allowing lipopolysaccharide (LPS) and other microbial metabolites to enter circulation. LPS activates Kupffer cells and promotes liver inflammation, amplifying the inflammatory tone already present in insulin-resistant metabolic states.

Disruptions in this axis impair liver regeneration, hinder mitochondrial recovery, and contribute to the chronicity of steatosis. Over time, impaired gut–liver communication becomes a central contributor to persistent inflammation, reduced metabolic flexibility, and progression to steatohepatitis.

Lifestyle medicine approaches to treatment

In addition to medical treatment strategies, integrative health approaches play a central role in restoring metabolic flexibility, supporting mitochondrial function, and addressing the behavioral and environmental drivers that shape the metabolic milieu in which MASLD develops.

Evidence supports dietary therapies, physical activity, weight optimization, and emerging mitochondria-targeted strategies as practical components of a comprehensive approach.

Because mitochondrial dysfunction is central to the pathogenesis of MASLD, multiple therapeutic strategies aim to restore mitochondrial function. Lifestyle interventions, including caloric restriction, exercise, and nutrient-dense diets, remain the most broadly effective and safest means of improving mitochondrial health.

Nutrition and dietary patterns

The international dietary consensus on MASLD emphasizes an overall energy-controlled, nutrient-dense pattern tailored to individual metabolic and cultural needs. Caloric reduction of approximately 500-750 kcal per day can significantly reduce liver fat, but qualitative dietary composition also matters.

Mediterranean-style diets that are rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil consistently improve hepatic steatosis, insulin sensitivity, and cardiometabolic markers.

Monounsaturated fats and omega-3 fatty acids appear to shift fats away from storage and help mitigate inflammatory signaling, while polyphenols may activate antioxidant pathways to counteract oxidative stress. Conversely, diets high in added sugars make mitochondrial oxidative stress worse and accelerate steatosis.

Reducing ultra-processed foods, refined carbohydrates, and saturated fats is therefore central to decreasing toxin loads.

Fermentable fibers and plant-based diversity also support a healthier gut microbiome by enhancing short-chain fatty acid (SCFA) production, improving gut barrier integrity, and enhancing bile acid signaling. These mechanisms can directly improve liver function via the gut-liver axis.

Physical activity and movement

Regular physical activity improves MASLD through several interlocking physiologic pathways, many of which operate independently of weight loss. Exercise increases skeletal muscle glucose uptake, reduces circulating insulin levels, and improves metabolic flexibility, thereby reducing the liver’s burden of chronically absorbing excess substrates that other tissues cannot metabolize.

Aerobic training enhances mitochondrial biogenesis, improving whole-body oxidative capacity and reducing the burden of lipids that would otherwise be diverted to the liver.

Resistance training adds a unique advantage by increasing lean muscle mass, expanding the body’s metabolic ‘sink’ for glucose and fatty acids, and improving insulin sensitivity.

Several trials demonstrate meaningful reductions in steatosis with exercise alone, and this makes exercise a compelling intervention for weight loss and positions physical activity as a form of metabolic conditioning.

In conclusion

MASLD is ultimately a reflection of how our modern environment interacts with human physiology. When the metabolic load exceeds the body’s capacity to adapt, the liver becomes the first place where this imbalance becomes visible. The encouraging piece is that these pathways are not fixed. By improving mitochondrial function, reducing inflammatory burden, and supporting metabolic flexibility through nutrition and movement, we can meaningfully shift the terrain in which MASLD develops. Understanding the mechanisms behind the diagnosis gives us leverage, and with that leverage comes the opportunity to create measurable change.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Dayal, U., Soni, U., Bansal, S., Aggarwal, K., Chennupati, C., Kanagala, S. G., Gupta, V., Munjal, R. S., & Jain, R. (2025). MAFLD: Exploring the systemic effects beyond liver. Journal of Community Hospital Internal Medicine Perspectives, 15(1), 42–48. https://doi.org/10.55729/2000-9666.1426

Fouad, Y., Alboraie, M., & Shiha, G. (2024). Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease. Hepatology International, 18(Suppl 2), 827–833. https://doi.org/10.1007/s12072-024-10704-3

Hu, Y., Hu, X., Jiang, L., Luo, J., Huang, J., Sun, Y., Qiao, Y., Wu, H., Zhou, S., Li, H., Li, J., Zhou, L., & Zheng, S. (2025). Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease. EBioMedicine, 111, 105482. https://doi.org/10.1016/j.ebiom.2024.105482

Hu, Z., Yue, H., Jiang, N., & Qiao, L. (2025). Diet, oxidative stress and MAFLD: A mini review. Frontiers in Nutrition, 12, 1539578. https://doi.org/10.3389/fnut.2025.1539578

Lai, S., Tang, D., & Feng, J. (2025). Mitochondrial targeted therapies in MAFLD. Biochemical and Biophysical Research Communications, 753, 151498. https://doi.org/10.1016/j.bbrc.2025.151498

Li, X., Chen, W., Jia, Z., Xiao, Y., Shi, A., & Ma, X. (2025). Mitochondrial dysfunction as a pathogenesis and therapeutic strategy for metabolic-dysfunction-associated steatotic liver disease. International Journal of Molecular Sciences, 26(9), 4256. https://doi.org/10.3390/ijms26094256

Mantovani, A., & Dalbeni, A. (2023). NAFLD/MAFLD: New evidence. International Journal of Molecular Sciences, 24(8), 7241. https://doi.org/10.3390/ijms24087241

Pan, J., Wu, F., Chen, M., He, J., Gu, Y., Pei, L., Lai, X., Zhang, Z., & Yang, L. (2024). Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999–2018. Diabetes & Metabolism, 50(6), 101562. https://doi.org/10.1016/j.diabet.2024.101562

Peng, H. Y., Lu, C. L., Zhao, M., Huang, X. Q., Huang, S. X., Zhuo, Z. W., Liu, J., Lu, Y. P., & Lv, W. L. (2025). Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders. BMC Gastroenterology, 25(1), 372. https://doi.org/10.1186/s12876-025-03912-0

Pennisi, G., Infantino, G., Celsa, C., Di Maria, G., Enea, M., Vaccaro, M., Cannella, R., Ciccioli, C., La Mantia, C., Mantovani, A., Mercurio, F., Tilg, H., Targher, G., Di Marco, V., Cammà, C., & Petta, S. (2024). Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies. Liver International, 44(11), 2939–2949. https://doi.org/10.1111/liv.16075

Xue, Y., Xu, J., Li, M., & Gao, Y. (2022). Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters. Frontiers in Endocrinology, 13, 951689. https://doi.org/10.3389/fendo.2022.951689

Zeng, X. F., Varady, K. A., Wang, X. D., Targher, G., Byrne, C. D., Tayyem, R., Latella, G., Bergheim, I., Valenzuela, R., George, J., Newberry, C., Zheng, J. S., George, E. S., Spearman, C. W., Kontogianni, M. D., Ristic-Medic, D., Peres, W. A. F., Depboylu, G. Y., Yang, W., Chen, X., … Zheng, M. H. (2024). The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus. Metabolism: Clinical and Experimental, 161, 156028. https://doi.org/10.1016/j.metabol.2024.156028

Zheng, Y., Wang, S., Wu, J., & Wang, Y. (2023). Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: New insights from pathogenic mechanisms to clinically targeted therapy. Journal of Translational Medicine, 21(1), 510. https://doi.org/10.1186/s12967-023-04367-1

Zhou, X. D., Cai, J., Targher, G., Byrne, C. D., Shapiro, M. D., Sung, K. C., Somers, V. K., Chahal, C. A. A., George, J., Chen, L. L., Zhou, Y., Zheng, M. H., & CHESS-MAFLD Consortium. (2022). Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovascular Diabetology, 21(1), 270. https://doi.org/10.1186/s12933-022-01697

But that isn’t the real story.

Behind the diagnosis lies an incredibly structured, predictable, and measurable physiological progression. High blood pressure doesn’t just happen. It slowly emerges through years of biochemical shifts, microvascular changes, chronic stress physiology, hormonal dysregulation, endothelial injury, and sustained circulatory overload.

Essential hypertension is a long-term process of cardiovascular remodeling, and people can be asymptomatic for a very long time.

Clinically, essential hypertension is defined as persistently elevated blood pressure without an identifiable secondary cause. This means there is no specific underlying disease causing it. There is no presence of kidney disease, sleep apnea, endocrine disorder, medication effect, etcetera. If any of these are present, it may instead become secondary hypertension, which is not addressed in this article.

While there is no single trigger for essential hypertension, there is a predictable physiological pattern. It is a multifactorial, systems-level disease that can arise from:

• endothelial dysfunction

• reduced nitric oxide availability

• chronic low-grade inflammation

• sodium handling differences

• genetics (strong family patterns)

• lifestyle contributors (diet, movement, stress, sleep)

Systolic and diastolic numbers are both clinically significant

Systolic pressure represents the force the heart must generate to push blood through the arterial system. As arteries stiffen, a defining feature of essential hypertension, systolic pressure rises and becomes a strong predictor of cardiovascular events, especially after age 50. Large epidemiological studies, including the Framingham Heart Study and major meta-analyses, show that higher systolic pressure is closely associated with heart attack, stroke, and overall mortality.

Diastolic pressure, on the other hand, reflects the resistance in the arteries when the heart is resting. Elevated diastolic pressure impairs coronary perfusion and increases mechanical stress on small vessels throughout the body, contributing to microvascular injury in the kidneys, retina, and brain. Diastolic hypertension is particularly important in younger adults, where increased vascular tone (not arterial stiffness) is the predominant driver. Evidence shows that isolated diastolic hypertension still increases long-term cardiovascular risk.

Let’s look at the physiology

At the center of hypertension is endothelial dysfunction. Our endothelium is a thin, intelligent, highly metabolically active tissue that lines every blood vessel in the body. It regulates vascular tone, blood flow, nitric oxide production, inflammation, clotting, and intercellular communication. In early hypertension, endothelial cells gradually lose their ability to produce sufficient nitric oxide. Without it, vessels cannot relax effectively, leading to persistent vasoconstriction. This increases resistance and forces the heart to generate more pressure to move blood forward.

Low-grade inflammation compounds this dysfunction. Inflammatory mediators interfere with the creation of nitric oxide and increase oxidative stress within the vessel wall. A slow-corrosive process unfolds as reactive molecules damage the endothelial lining and impair normal signaling. Over time, smooth muscle cells in the arterial wall begin to thicken, a maladaptive form of structural remodeling that stiffens the vessels and narrows the lumen.

Our sympathetic nervous system plays an equally important role in the pathogenesis of essential hypertension. Chronic physical, emotional, metabolic, or environmental stress can create a persistent nervous system overdrive. This elevates heart rate, constricts blood vessels, and signals the kidneys to retain sodium and water. Layered on top of this is the renin-angiotensin-aldosterone system (RAAS), which becomes hyperactive. Angiotensin II drives vasoconstriction and inflammation, while aldosterone increases sodium retention and promotes fibrosis in both vessels and cardiac tissue.

Over the years, this combination gradually transforms the cardiovascular landscape. Arteries grow thicker and less elastic. The heart works harder against elevated resistance. The kidneys receive blood at pressures they were not designed to manage, accelerating microvascular damage. The eyes, brain, and vascular endothelium show changes long before symptoms emerge, which is why essential hypertension is often called a ‘silent disease’: the remodeling occurs quietly, long before blood pressure numbers become alarming.

The good news is that these same systems remain responsive to intervention.

Restoring vascular health is about improving communication among the vessels, kidneys, and the autonomic nervous system. The cardiovascular system adapts to the environment we give it. With small, intentional choices practiced daily, the trajectory of essential hypertension can shift, sometimes profoundly.

Evidence-based integrative modalities for hypertension

Lifestyle and integrative interventions meaningfully improve vascular function, autonomic balance, and nitric oxide availability. These approaches complement (never replace) medication by addressing upstream physiology. Here are three clinically supported modalities you can start integrating right now:

Slow breathing and autonomic regulation. Breathing at ~6 breaths per minute improves baroreflex sensitivity and strengthens parasympathetic activity. Just 2 minutes, twice daily, begins shifting autonomic tone. Other benefits include:

• reduced peripheral resistance

• improved HRV

• decreased sympathetic activation

• measurable reductions in both systolic and diastolic pressure

Dietary nitrates (beets, arugula, leafy greens). Nitrate-rich plants generate nitric oxide via the nitrate-nitrite-NO pathway, bypassing impaired endothelial nitric oxide synthase activity. Even small doses of beetroot juice can produce clinically significant improvements. Effects include:

• enhanced vasodilation

• reduced arterial stiffness

• lower blood pressure

• improved exercise tolerance

Aerobic conditioning and Zone 2 training. Moderate-intensity aerobic exercise reverses many vascular abnormalities observed in essential hypertension. Walking, swimming, cycling, or any form of Zone 2 cardio performed 3-4 times per week consistently improves blood pressure.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Benjamim, C. J. R., Porto, A. A., Valenti, V. E., Sobrinho, A. C. da S., Garner, D. M., Gualano, B., & Bueno Júnior, C. R. (2022). Nitrate derived from beetroot juice lowers blood pressure in patients with arterial hypertension: A systematic review and meta-analysis. Frontiers in Nutrition, 9, 823039. https://doi.org/10.3389/fnut.2022.823039

Hall, J. E., & Hall, M. E. (2020). Guyton and Hall textbook of medical physiology (14th ed.). Elsevier.

Joseph, C. N., et al. (2023). Slow breathing and autonomic regulation in hypertension: A systematic review. Journal of Hypertension, 41(3), 345–356.

Lewington, S., Clarke, R., Qizilbash, N., Peto, R., & Collins, R. (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet, 360(9349), 1903–1913.

Lüscher, T. F. (2021). Endothelial dysfunction: The origin of atherosclerosis. European Heart Journal, 42(45), 4538–4550. https://doi.org/10.1093/eurheartj/ehab647

McEvoy, J. W., Daya, N., Rahman, F., Hoogeveen, R. C., Blumenthal, R. S., Shah, A. M., & Solomon, S. D. (2016). Association of isolated diastolic hypertension with cardiovascular outcomes. JAMA, 315(19), 2093–2100.

Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Journal of the American College of Cardiology, 71(19), e127–e248.

Because herbs work.

And because they work, they can also work against you in harmful ways. This is the part the wellness world sometimes skips. Herbal medicine is more than folk magic; it is biochemistry. Plants affect the same pathways as medications, influencing enzymes, neurotransmitters, immune signals, inflammatory cascades, and even mitochondrial behavior. If you’ve read my pieces on the Cell Danger Response or Gut Health + Chronic Disease, you already know how sensitive these systems are.

So when herbs are self-prescribed out of context, especially when taking medications, tiny physiological experiments are run on our bodies. Sometimes they are harmless, sometimes incredibly helpful, and sometimes they can interfere with the very pathways that keep you alive and well.

Let’s walk through what this actually means, clinically, because herb-drug interactions are predictable, documented, and preventable when we treat herbs less like casual supplements.

St. John’s Wort: The most misunderstood herb in modern wellness

Hypericum perforatum is one of the most effective botanicals for mild to moderate depression. It is also among the most disruptive herbs in pharmacology. Not because it is dangerous, but because it strongly influences the enzymes that process medications.

Quick physiology refresher: When I talk about CYP(insert a letter and number combo) or cytochrome P450 here, I am talking about your liver’s detox machinery. Specifically, these are the enzymes responsible for breaking down medications, hormones, and plant compounds. Think of them like traffic lights in your internal chemistry. Some herbs speed up those lights, so medications like SSRIs or statins clear faster. Others slow them down, causing levels to accumulate. This is not obscure science; it’s the difference between a medication working, not working, or working too well.

St. John’s Wort induces CYP3A4 and p-glycoprotein, two of the busiest ‘traffic lights’ in your system. These pathways clear medications like:

• antidepressants

• birth control

• immunosuppressants

• benzodiazepines

• chemotherapeutics

• HIV medications

• anticoagulants

• antiepileptics

When those enzymes increase, medications drop below therapeutic levels. This is why St. John’s Wort can destabilize mood, interfere with contraception, or reduce the effectiveness of transplant drugs.

The herb isn’t the villain; it is the context that matters.

Ginkgo: Cognitive support with a physiological edge

Ginkgo biloba is marketed as a benign 'brain fog’ herb. But ginkgo’s real mechanism is its ability to modulate platelet-activating factor, which influences blood viscosity and microcirculation.

This is helpful in controlled settings, especially for older adults with cognitive changes. The part that gets lost is that if a client is also taking a blood thinner (including aspirin), they have now stacked mechanisms that can increase bleeding risk.

In practice, this matters most for older adults, people taking NSAIDs regularly, individuals with clotting disorders, and anyone scheduled for surgery. In an integrative clinic, this interaction is managed. In the Instagram wellness culture, it is not mentioned at all.

Licorice: A tea that acts like a hormone

Whole-root licorice Glycyrrhiza glabra is fantastic for ulcer repair and certain adrenal presentations. The issue is that the glycyrrhizin contained therein is a compound that increases cortisol activity by inhibiting 11β-hydroxysteroid dehydrogenase, shifting electrolyte balance by retaining sodium and wasting potassium.

Translated: licorice can raise blood pressure, trigger palpitations, cause swelling, and interfere with medications like diuretics or steroids.

Kava: For anxiety, with physiological considerations

Piper methysticum is one of the most effective herbs for anxiety and muscular tension. Used within traditional Pacific Island cultures, it was prepared intentionally and with deep cultural knowledge. Modern extraction methods, inconsistent sourcing, and genetic differences in metabolic enzymes all change how the body processes kavalactones. Add chronic stress or existing hepatic strain, and the margin for error narrows considerably. The rare cases of hepatotoxicity reported in the early 2000s emerged because the modern use of kava bore little resemblance to its traditional context.

Kava has an important place clinically. It is effective and powerful, but it requires discernment, appropriate duration, and a respect for dosage.

Berberine: A metabolic powerhouse with real consequences

Berberine is everywhere right now, marketed as a ‘natural Ozempic.’ But berberine does not work through one single pathway. It modifies:

• bacterial species in the gut

• carbohydrate metabolism

• bile acid signaling

• hepatic glucose production

• AMPK activation

For a client not on medication, this can be incredibly helpful; for someone on metformin or insulin, however, this can cause hypoglycemia or alter how other drugs are absorbed.

Plants should never be used long-term, either. Some herbs have constituents the human body cannot safety metabolize or excrete in large, chronic amounts. For example, Pyrrolizidine alkaloids found in comfrey Symphytum spp., coltsfoot, and borage can damage hepatic blood vessels over time.

Why am I even writing about this?

In my experience, those with acute or chronic illness that disrupts their quality of life, are desperate to feel better. I learn about clients taking herbs because they are seeking relief from symptoms that conventional medicine has ignored. I understand why, and I support the instinct to do so; herbal medicine can be powerful. I also respect that herbs influence the same physiological pathways I write about in my articles on chronic disease, mitochondrial stress, and metabolic resistance.

Natural does not mean harmless or limitless. Natural means biologically active, which is why they work.

If you want to use herbs safely…

Start working alongside those who understand the interactions between herbs and your physiology. A trained integrative medicine practitioner, clinical herbalist, naturopathic doctor, or functional nutritionist helps you map out how your body processes plant compounds, how medications behave in your system, and what your physiology can and can’t tolerate.

The other part of the equation, the part that matters long-term, is you learning to ask better questions. You don’t need to be a biochemist you just need enough curiosity to understand the basics. This is exactly what I meant when I wrote Seeking Evidence in Herbal Medicine: Find a middle place where intuition, tradition, and physiology meet. It doesn’t have to be a one or the other approach, but a grounded understanding of how your body works paired with the instinct that draws you to plants in the first place.

Herbal medicine is about ownership. It is about understanding that your body is a living system with pathways, enzymes, signals, and checks and balances. Explore how your body works, or find someone who truly understands. Read the research. Ask your practitioner real questions. Knowledge creates agency, and with the right guidance, that agency becomes the foundation for real healing.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Arlt, V. M., Stiborova, M., & Schmeiser, H. H. (2002). Aristolochic acid as a probable human cancer hazard in herbal remedies: A review. Mutagenesis, 17(4), 265–277. https://doi.org/10.1093/mutage/17.4.265

Bone, K., & Mills, S. (2013). Principles and practice of phytotherapy: Modern herbal medicine (2nd ed.). Churchill Livingstone.

European Medicines Agency. (2021). Assessment report on Glycyrrhiza glabra L.

https://www.ema.europa.eu

Fu, P. P., Xia, Q., Lin, G., & Chou, M. W. (2004). Pyrrolizidine alkaloids—Genotoxicity, metabolism, enzymes, metabolic activation, and mechanisms. Drug Metabolism Reviews, 36(1), 1–55. https://doi.org/10.1081/DMR-120028426

Izzo, A. A., & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs, 69(13), 1777–1798. https://doi.org/10.2165/11317010-000000000-00000

Mills, S., & Bone, K. (2005). The essential guide to herbal safety. Elsevier Churchill Livingstone.

Teschke, R., Schwarzenboeck, A., & Hennermann, K. H. (2008). Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. European journal of gastroenterology & hepatology, 20(12), 1182–1193. https://doi.org/10.1097/MEG.0b013e3283036768

Living in California wine country, then relocating to the land of the local pub in London, I am implicated in this as well. Yet the more research I do on metabolic health, inflammation, and chronic disease, the clearer the picture becomes, and it is not a flattering one. Behind the marketing lies one of the most underestimated drivers of metabolic illness and chronic inflammation.

Once we have a drink, alcohol hijacks our biochemistry. It consumes a coenzyme called NAD+, which is required for mitochondrial energy production and repair. It generates reactive oxygen species (ROS), driving oxidative stress, lipid peroxidation, and inflammation.

Over time, this cascade contributes to insulin resistance, hepatic steatosis, endothelial dysfunction, and neuroinflammation. These are the same biological pathways that underpin Type 2 diabetes, cardiovascular disease, and cognitive decline.

So, is it only heavy drinking that does damage, or does a single drink matter? Research increasingly shows that even small amounts can shift metabolism in the wrong direction.

There is truly no safe dose.

One beer or a glass of wine still depletes NAD+ and activates the same oxidative cascade. The myth of ‘healthy moderation’ was built on outdated epidemiology, and newer studies reveal what biochemists have long known: ethanol is a mitochondrial toxin.

Alcohol also dismantles the gut-liver-brain axis, weakening the intestinal barrier, altering microbial balance, and allowing bacterial endotoxins to enter circulation. This translocation activates immune signaling through toll-like receptors and drives systemic inflammation.

With enough time, this biological stress amplifies metabolic syndrome, the cluster of insulin resistance, dyslipidemia, hypertension, and abdominal fat accumulation that underlies most chronic disease.

Metabolic syndrome is not simply a lifestyle diagnosis. It is a systemic breakdown in energy regulation. Alcohol accelerates that process by increasing triglycerides, promoting hepatic fat accumulation, and depleting NAD+ reserves needed for mitochondrial repair. By impairing mitochondrial efficiency, altering neurotransmitter signaling, and spiking blood sugar, alcohol produces the very anxiety, fatigue, and irritability it claims to relieve.

Restoration of our health comes from our body’s ability to repair, and alcohol erodes that capacity. In our modern culture, which has become the poster child for rampant stress and inflammation, not drinking may be the greatest act of love we can show ourselves.

This piece builds on the threads from my earlier essays — The Cell Danger Response and Restoring Harmony in Our Immune System, both of which explore how chronic stress, oxidative load, and energy imbalance shape our biology. Alcohol sits at the center of that conversation because it amplifies every pathway that drives inflammation and mitochondrial dysfunction. The more we understand these mechanisms, the more clearly we see that resilience isn’t found in moderation; it’s built through restoration.

Leave a comment

References

Fairfield, B., & Schnabl, B. (2021). Gut dysbiosis as a driver in alcohol-induced liver injury. JHEP Reports, 3(1), 100220. https://doi.org/10.1016/j.jhepr.2020.100220

Kang, H., Park, Y. K., & Lee, J. Y. (2021). Nicotinamide riboside attenuates inflammation and oxidative stress by activating SIRT1 in alcohol-stimulated macrophages. Laboratory Investigation, 101(9), 1225–1237. https://doi.org/10.1038/s41374-021-00599-1

Lee, J., Lee, J.-Y., & Kang, H. (2025). Excessive alcohol consumption: A driver of metabolic dysfunction and inflammation. Frontiers in Toxicology, 7, 1670769. https://doi.org/10.3389/ftox.2025.1670769

León, B. E., Kang, S., Franca-Solomon, G., Shang, P., & Choi, D. S. (2021). Alcohol-induced neuroinflammatory response and mitochondrial dysfunction on aging and Alzheimer’s disease. Frontiers in Behavioral Neuroscience, 15, 778456. https://doi.org/10.3389/fnbeh.2021.778456

World Health Organization. (2023, January 4). No level of alcohol consumption is safe for our health. https://www.who.int/news/item/04-01-2023-no-level-of-alcohol-consumption-is-safe-for-our-health

Our skin directly reflects how our internal systems are managing nutrients, stress, and inflammation. When the skin becomes congested or inflamed, it’s often echoing disturbances happening deeper with glucose regulation, oxidative stress, or microbial imbalance.

Modern research increasingly links acne to insulin resistance, dietary patterns, and altered gut-skin communication. Pathways once associated mainly with diabetes and obesity are now recognized as key regulators of sebaceous gland activity and immune signaling in the skin. This makes acne not just a dermatologic condition but an early marker of metabolic stress.

Understanding acne through an integrative lens reframes it as a visible sign of systemic imbalance and one that responds best when we restore rhythm internally and reinforce the skin barrier externally.

Acne as a disease

Acne is a chronic inflammatory disease of the pilosebaceous unit characterized by hyper-keratinization, overproduction of sebum, skin microbiome dysbiosis, and the activation of our immune system. Androgens that regulate growth, like testosterone and DHEA, stimulate the sebaceous glands to produce more oil, changing their makeup to include more squalene and wax esters (fats that oxidize easily).

When squalene oxidizes into squalene peroxide, it becomes highly inflammatory, damaging the follicle wall and fueling acne-causing bacteria. In short, excess androgens make skin oilier, and the oil itself is more reactive and irritating.

This in turn fuels reactive oxygen species (ROS) and pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α, which are chemical messengers from our macrophage cells. The result is follicle obstruction, rupture, and inflammation.

High-glycemic diets and dairy intake stimulate insulin and IGF-1, which in turn activate the body’s internal ‘growth switch’ (mTORC1) that tells cells to build, store, and secrete. When mTORC1 is stuck in the ‘on’ position, sebaceous glands go into overdrive, and keratinocytes inside the follicle multiply faster than they should. This same pathway suppresses a transcription factor (Fox01) that keeps antioxidant defenses and normal cell turnover in balance.

To exacerbate this process, when Fox01 is downregulated, the skin loses part of its antioxidant shield. ROS accumulates, which damages nearby lipids and proteins, and the skin’s antioxidant systems can’t keep up. Once ROS accumulate, they further oxidize sebum and activate signaling for cytokine release, and drive even more mTORC1 activity, turning acne into a self-reinforcing inflammatory loop. Over time, this inflammatory cascade amplifies IL-17, the immune signal that deepens redness, swelling, and sensitivity in active lesions.

It always comes back to the gut

Research shows that people with acne often have fewer beneficial species in the gut microbiome, like Bifidobacterium and Lactobacillus, and more inflammatory families such as Proteobacteria and Bacteroidetes.

Read more on the link between gut health and chronic inflammation.

Short-chain fatty acids (SCFAs) such as butyrate and propionate, normally produced by bacterial fermentation of dietary fiber, are critical regulators of gut barrier integrity and glucose homeostasis. A reduction in these fatty acid-producing species (that feed on foods like onions, garlic, carrots, pears, and Jerusalem artichoke) contributes to insulin dysregulation and increases inflammation.

Rebalancing the gut microbiome through diet or targeted prebiotic and polyphenol interventions may therefore improve both metabolic and dermatologic outcomes. Green tea polyphenols, particularly EGCG, have demonstrated direct benefits in acne, reducing inflammatory lesions and sebum production through antioxidant and anti-androgenic effects.

Read more about the benefits of EGCG to our immune system balance.

These shifts mirror the patterns also seen in metabolic syndrome, suggesting shared roots. The same metabolic imbalances that drive insulin resistance and inflammation in metabolic syndrome (oxidative stress, gut dysbiosis, and chronic, low-grade inflammation) are mirrored in acne. In that sense, acne is a visible sign from the metabolic system that something deeper may be out of rhythm.

Our skin microbiome

Our skin barrier mirrors the gut barrier in structure and function, and both rely on lipid integrity, tight-junction proteins, and microbial balance to maintain balance. Clients with acne often exhibit increased skin moisture loss, elevated skin pH, and decreased microbial diversity, indicating barrier compromise.

Loss of filaggrin, a protein that stacks and binds skin cells together like mortar between bricks, weakens cohesion and hydration in the outer layer. Reduced claudin-1, one of the microscopic ‘zippers’ sealing neighboring cells, and desmoglein-1, a structure ‘rivet’ anchoring them for strength, further undermines barrier integrity. When these proteins decline, moisture escapes and irritants can penetrate, priming the skin for inflammation.

Repairing the skin barrier, therefore, becomes a therapeutic priority alongside regulating systemic metabolic drivers.

Read more on the importance of our microbiome network.

Integrative support for treatment

The integrative management of acne combines internal metabolic rebalancing with topical barrier restoration. From an internal perspective, the goal is to quiet mTORC1 and IGF-1 signaling while restoring microbial balance and insulin sensitivity. This may be achieved through:

1. A low-glycemic, anti-inflammatory diet that emphasizes a roughly 45% protein, 35% complex carbohydrate, 20% unsaturated fat balance.

2. Reduction (or even elimination) of dairy and refined carbohydrates since dairy contains IGF-1 and androgen precursors that amplify sebaceous activity. High sugar intake overstimulates insulin and mTORC1, worsening oil production.

3. Eliminate trans- and saturated fat, as these increase inflammatory messages and thicken sebum.

4. Increase omega-3 fatty acids (EPA + DHA) because they have been shown to stabilize the skin barrier by reducing IL-1β and IL-17 signaling.

5. Ensure intake of nutrients like vitamin C and E, selenium, and polyphenols from green tea or berries to counter oxidative stress through an increase in antioxidants.

External treatment for acne that shows the greatest effect is vitamin A derivatives like retinol, which remain the gold standard for normalizing and enhancing skin turnover. However, the most effective approach that clears skin and restores the terrain within blends metabolic recalibration (diet, micronutrients, gut support) with barrier restoration (topical vitamin A).

Closing thoughts

When viewed through an integrative lens, acne vulgaris becomes a signal of internal metabolic discord rather than merely a surface defect. Addressing both diet and barrier health allows practitioners to modulate the shared pathways linking acne, dysbiosis, and metabolic dysfunction.

Leave a comment

References

Deng, Y., Wang, F., & He, L. (2024). Skin Barrier Dysfunction in Acne Vulgaris: Pathogenesis and Therapeutic Approaches. Medical science monitor : international medical journal of experimental and clinical research, 30, e945336. https://doi.org/10.12659/MSM.945336

Ilari, S., Nucera, S., Morabito, L., Caminiti, R., Mazza, V., Ritorto, G., Ussia, S., Passacatini, L. C., Macrì, R., Scarano, F., Serra, M., Scali, E., Maiuolo, J., Oppedisano, F., Palma, E., Muscoli, S., Proietti, S., Tomino, C., Mollace, V., & Muscoli, C. (2024). A Systematic Review of the Effect of Polyphenols on Alterations of the Intestinal Microbiota and Shared Bacterial Profiles Between Metabolic Syndrome and Acne. Nutrients, 16(21), 3591. https://doi.org/10.3390/nu16213591

Pizzorno, J. E. & Murray, M. T. (2020). Textbook of Natural Medicine - 2 volume set (5th ed). Elsevier. ISBN: 9780323523783

Salemi, M., Dadkhahfar, S., Tehranchinia, Z., Razzaghi, Z., & Ghalamkarpour, F. (2025). Evaluating the Association Between Acne Vulgaris and Diet: An Exploratory Study on Patient Beliefs and Perceptions. Journal of cosmetic dermatology, 24(7), e70285. https://doi.org/10.1111/jocd.70285

The innate system provides immediate, broad defense, while the adaptive system develops specificity and memory over time. Together, they represent both speed and precision, two halves of a continuous feedback system that determines whether the body restores balance or sustains inflammation.

Innate and adaptive immunity

Innate immunity is the body’s rapid first line of defense. It includes physical barriers such as the skin and mucosa, along with immune cells that recognize general ‘danger signals.’ These cells (macrophages, neutrophils, dendritic cells, and natural killer cells) detect molecular patterns through pattern recognition receptors, which initiate inflammation and cytokine release.

While innate immunity lacks antigen-specific memory, it demonstrates an adaptive-like capacity called trained immunity, in which repeated exposures prime myeloid cells for stronger responses.

In contrast, adaptive immunity is slower but highly specific. It relies on lymphocytes, T cells, and B cells, which recognize unique antigens and form immunologic memory. T cells coordinate and execute cellular responses while B cells differentiate into plasma cells that produce antibodies. The adaptive branch develops precision over time, learning from each exposure to ensure faster, more effective responses to future threats.

Though distinct, these two systems are deeply interdependent. Innate immunity activates and guides adaptive responses through cytokine signaling and antigen presentation, while adaptive responses refine and regulate innate activity to prevent excessive inflammation.

Mechanisms of cell-mediated and humor immunity

Adaptive immunity operates through cell-mediated and humoral mechanisms. Cell-mediated immunity relies on T lymphocytes. Antigen-presenting cells (APCs) such as dendritic cells display processed antigen on major histocompatibility complex (MHC) molecules. CD4 helper T cells release cytokines that direct immune coordination, while cytotoxic T cells directly destroy infected or abnormal cells. This mechanism primarily targets intracellular pathogens, such as viruses and certain bacteria.

Humoral immunity, by contrast, involves B lymphocytes, which differentiate into plasma cells and secrete antibodies that circulate through the blood and lymph. These antibodies neutralize pathogens, mark them for phagocytosis, or activate complement proteins to enhance clearance. Together, these two branches of adaptive immunity ensure defense across both extracellular and intracellular environments.

Integrative modulation of the immune response

Complementary and alternative medicine (CAM) therapies often focus on regulating immune balance rather than merely stimulating immune activity. One evidence-based example is tea polyphenols, notably epigallocatechin-3-gallate (EGCG), a bioactive compound from Camellia sinensis (Green Tea). These plant-derived antioxidants have demonstrated potent immunomodulatory effects through their ability to modulate redox signaling, cytokine expression, and gut microbiota composition, and in human studies, daily intake of:

· 2–3 cups of green tea providing roughly 250–500 mg total catechins and 150–200 mg EGCG was associated with measurable antioxidant and cytokine-modulating effects, and

· Short-term supplementation up to 800 mg EGCG per day has been shown to down-regulate inflammatory markers such as IL-6 and IL-1β.

These plant-derived compounds modulate redox signaling, cytokine balance, and gut microbiota composition, supporting immune regulation rather than overstimulation.

EGCG enhances the antioxidant pathway, reducing oxidative stress and suppressing excessive pro-inflammatory cytokines such as IL-6 and IL-1β. This mechanism protects immune cells from oxidative injury while maintaining the body’s ability to mount antiviral and antimicrobial defenses. Additionally, tea polyphenols modulate the gut-lung axis, increasing beneficial bacteria such as Bifidobacterium and Akkermansia, and enhancing short-chain fatty acid (SCFA) production. These changes support mucosal integrity and influence T-helper (Th1/Th2) balance, steering immune activity away from chronic inflammation toward regulatory equilibrium (Hong et al., 2022).

From an integrative health perspective, tea polyphenols represent and natural, evidence-based CAM approach that bridges nutrition and immune science. Rather than ‘boosting’ the immune system, they exemplify how botanical compounds can harmonize immune function, restoring balance through redox regulation, microbiome modulation, and cytokine control.

In conclusion

Innate and adaptive immunity represent two essential and complementary dimensions of immune defense. The innate branch provides immediate containment through pattern recognition and inflammation, while the adaptive branch refines the response with targeted precision and long-term memory. Their interplay is governed by feedback, energy balance, and signaling pathways that can be influenced through integrative strategies. CAM interventions such as tea polyphenols demonstrate how natural compounds can support immune regulation by modulating oxidative stress and microbial ecology. True immune health, therefore, lies not in constant activation but in maintaining dynamic balance across these interconnected systems.

Leave a comment

References

Carpenter, S., & O’Neill, L. A. J. (2024). From periphery to center stage: 50 years of advancements in innate immunity. Cell, 187(9), 2030–2051. https://doi.org/10.1016/j.cell.2024.03.036

Hong, M., Cheng, L., Liu, Y., Wu, Z., Zhang, P., & Zhang, X. (2022). A Natural Plant Source-Tea Polyphenols, a Potential Drug for Improving Immunity and Combating Virus. Nutrients, 14(3), 550. https://doi.org/10.3390/nu14030550

Phillip West, A., & McGuire, P. J. (2025). Tipping the balance: innate and adaptive immunity in mitochondrial disease. Current opinion in immunology, 95, 102566. https://doi.org/10.1016/j.coi.2025.102566

Sun, L., Wang, X., Saredy, J., Yuan, Z., Yang, X., & Wang, H. (2020). Innate-adaptive immunity interplay and redox regulation in immune response. Redox biology, 37, 101759. https://doi.org/10.1016/j.redox.2020.101759

In Parts I through III of this series, I explored how the gut and mitochondria serve as the body’s communication hubs. These articles discussed how the microbiome influences metabolism, immunity, and even brain function. This fourth and final installment delves one layer deeper into the language of stress itself: how chronic psychological, environmental, or metabolic stressors can cause our cells to become stuck in a state of danger, locking the body in a loop of inflammation and fatigue that underlies much of modern chronic disease.

Every cell is listening

Each cell in the human body is a living sensor, continually interpreting signals from its environment. It listens for shifts in nutrient availability, oxidative stress, and microbial or chemical threats.

When something feels ‘off,’ the cell doesn’t wait for instructions from the brain or immune system, it launches it’s own emergency protocol, a (theoretical) metabolic program known as the Cell Danger Response (CDR).

The CDR is not a disease state; it is the ancient survival reflex that halts normal activity of growth, repair, and communication so that cells can isolate, contain, and neutralize a threat. When this defensive program fails to resolve, however, the body becomes stuck in a perpetual state of ‘on.’ Healing can stall, energy can wane, and chronic symptoms can begin to emerge.

The concept of the Cell Danger Response (CDR) was first articulated by Dr. Robert Naviaux (UC San Diego) to describe a unifying model of how cells respond to threat. The framework integrates decades of research on mitochondrial signaling, metabolism, and immune activation, but the specific construct of the “CDR” as a named, sequential healing program remains a theoretical synthesis, not a formally validated medical model, and it serves as a useful framework for understanding chronic dysregulation.

How cells translate stress into survival

As explored in Article 3 of this series, our mitochondria act as biosensors and communication hubs. They interpret various forms of stress, ranging from physical to emotional, chemical, or microbial, and determine whether a cell should remain in growth or shift into defense. The types of stress mitochondria respond to are wide-ranging:

• Biological stressors: chronic infections, viral reactivation, gut dysbiosis, and bacterial fragments such as lipopolysaccharides (LPS) that leak into circulation.

• Chemical and environmental stressors: heavy metals, pesticides, air pollution, and mold toxins, impair mitochondrial enzymes and elevate oxidative stress.

• Nutrient and metabolic stressors: insufficient cofactors (B vitamins, magnesium, CoQ10, amino acids) or overnutrition from refined foods that overwhelm redox balance.

• Physical and psychological stressors: overexercise, trauma, sleep deprivation, and persistent emotional strain, all of which activate the same biochemical pathways as infection or injury.

• Energetic overload: constant blue-light exposure, EMFs, and heat extremes that disrupt circadian signaling and mitochondrial communication.

In response, mitochondria shift from their most efficient oxygen-based metabolism, called oxidative phosphorylation (OXPHOS), to a faster but less efficient system known as glycolysis. Even when oxygen is available, stressed cells make this switch.

The purpose is about survival, as glycolysis allows a quick energy burst to fuel immune defenses and repair, but produces only a fraction of the energy that OXPHOS can generate. So when infection, toxins, or psychological stress are present, cells don’t need to make energy perfectly; they just need to make it fast enough to mount a defense. When glycolysis remains the cell’s primary source of energy creation, energy output remains low and unsustainable.

This change incurs additional costs, as OXPHOS slows and the production of reactive oxygen species (ROS) increases. While these molecules are often blamed for damage, at moderate levels, they serve as essential signals that activate genes that regulate inflammation and defense.

When the stress is short-lived, this response is life-saving, but if the triggers persist, ROS accumulate faster than antioxidant systems can neutralize them, creating a feedback loop of oxidative stress and inflammation.

When cellular alarms don’t switch off

As the mitochondria shift into defense, they release a series of biochemical alarms. Small fragments of mitochondrial DNA (mtDNA) leak into the cell and bloodstream through temporary membrane pores, functioning as damage-associated molecular patterns, serving as the cell’s internal fire alarm.

At the same time, energy production that is normally used for cell energy is released outside the cell. There, energy takes on a new role: a ‘danger signal’ that binds to purinergic receptors (notably P2X7) on immune cells, amplifying the inflammatory cascade.

For a brief time, this heightened state is protective and helps the body contain infection, remove toxins, and repair tissue. When the alarm remains active, the consequences spread far beyond the original threat. Repeated activation of these mitochondrial distress signals damages membranes, depletes antioxidants, and traps the cell in a loop of inflammation and energy depletion.

Clinically, this often looks like patients who struggle to recover: persistent fatigue, brain fog, low stress tolerance, or exercise intolerance despite normal lab results. The cellular machinery is functioning, but it is doing so under a standing order: “Stay alert, danger is still present!”

How cells rewire themselves under chronic stress

Prolonged activation of the CDR changes not just how cells make energy, but how they communicate and behave. This reprogramming resembles the Warburg effect, a metabolic pattern seen in both immune and cancer cells, where glucose is converted to lactate even when oxygen is abundant. This trade-off allows cells to prioritize defense over growth. They produce enough energy to survive but not enough to thrive.

Meanwhile, mitochondria and the cell nucleus fall out of sync. Normally, these two structures maintain an ongoing dialogue through small signaling peptides such as MOTS-c, which regulate gene expression and coordinate metabolic adjustments.

Under chronic stress, that dialogue weakens. Communication breakdowns mean that even when the external stressor has passed, the cell continues to behave as if it hasn’t. It remains metabolically rigid and unable to transition from survival back to regeneration.

Practitioners may recognize this pattern in clients who feel ‘stuck.’ Their bodies have adapted to long-term threat perception, and the cellular programs meant to help them survive are not preventing them from healing.

How our cells know it is safe to heal again

At the center of recovery lies a molecular switch known as NRF2. This is considered the body’s master regulator of antioxidant and detoxification pathways, and when oxidative stress rises from toxins, infection, or emotional strain, NRF2 moves into the nucleus and activates genes that create glutathione, antioxidant enzymes, and repair proteins.

It is, quite literally, the biochemical signal that it’s safe to rebuild. When NRF2 signaling is impaired from poor sleep, nutrient depletion, chronic inflammation, or toxic exposure, the cell remains locked in a defensive state. Energy continues to be spent on protection instead of regeneration.

Clinically, this manifests as individuals who struggle to bounce back, characterized by persistent fatigue, inflammatory reactivity, or slowed recovery despite doing ‘all the right things.’ Supporting NRF2 through phytonutrients (sulforaphane, curcumin, resveratrol), cruciferous vegetables, restorative sleep, rhythmic movement, and time in natural light helps re-engage this repair signal. These interventions are literal safety cues, reminding our body that a threat has passed, inviting the cell to return to balance.

When the body’s alarm won’t turn off

Another crucial component in the CDR is the NLRP3 inflammasome, an internal sensor that detects danger molecules released during stress. When energy, ROS, or mtDNA fragments accumulate, NLRP3 activates and releases inflammatory messengers (cytokines) such as interleukin-1β (IL-1β) and interleukin-18 (IL-18).

In acute phases, this system is beneficial because it calls immune cells to action and initiates repair. But chronic activation keeps the immune system in a low-grade state of alert. Over time, this sustained signaling contributes to autoimmunity, neuroinflammation, and metabolic dysfunction.

Interventions that reduce mitochondrial load, repair the gut barrier, optimize micronutrients, and manage psychosocial stress help quiet this inflammasome and re-establish immune tolerance. By restoring redox balance and improving mitochondrial communication, we allow the body to lower its defenses and begin repair.

How the body knows danger has passed

Inflammation is supposed to end. Once a threat is neutralized, the body must receive a clear biochemical signal that it’s safe to stand down. That signal comes from adenosine, which is produced when specialized enzymes (CD39 and CD73) break down energy outside the cell, and specialized compounds derived from Omega-3 (resolvins and protectins).

Together, these compounds actively promote tissue repair and signal the transition from defense to homeostasis. When adenosine binds to A2A receptors on immune and blood cells, it acts as a message of resolution, reducing chemical messaging from cytokines, improving circulation, and promoting tissue repair.

If this conversation process is impaired by the presence of toxins, chronic psychological stress, or disrupted metabolism, the ‘off switch’ for inflammation never fully engages. The body remains in defense, expending energy long after the threat has passed. The goal is not to suppress inflammation; it is to complete it, helping the body recognize that it is safe once again.

Clearing debris: how the body resets after defense

Once the alarms are quiet, the body needs to clean up the damage left behind. Autophagy, the process of recycling cellular components, and mitophagy, the targeted removal of damaged mitochondria, are essential for full recovery. When these pathways stagnate, dysfunctional organelles continue leaking ROS and mtDNA, perpetuating low-level inflammation.

Practices such as fasting, structured exercise, adequate sleep, and nutrient sufficiency gently reactivate these processes. Meanwhile, the gut-mitochondria-microbiome axis plays a crucial role in determining how effectively the body restores balance.

Dysbiosis or intestinal permeability allows bacterial fragments (like LPS) to enter circulation, keeping the mitochondria on alert. Restoring microbial diversity, strengthening the gut barrier, and replenishing mitochondrial cofactors (B vitamins, magnesium, CoQ10) help signal systemic safety. These are part of the same message: “It is time to rebuild.”

When healing requires a system reset

The CDR resolves only when cells collectively perceive safety. When energy release ceases, oxidative balance normalizes, and communication between mitochondria and the nucleus is restored. Recovery follows three guiding principles:

1. Reduce ongoing threats: remove infections, toxins, and chronic stressors

2. Support resolution: enhance NRF2 activity, adenosine signaling, and autophagy

3. Rebuild capacity: restore mitochondrial integrity, nutrient sufficiency, and microbial balance.

When these elements align, energy production returns to oxidative metabolism, inflammation resolves, and the system transitions from defense to regeneration.

Practitioner Takeaways

• The Cell Danger Response represents a protective adaptation, not pathology. Chronic illness often reflects a CDR that was not completed.

• Mitochondria integrate all forms of stress, including biological, chemical, and emotional, and translate them into energy and immune communication.

• Common presentations: fatigue, brain fog, inflammatory sensitivity, “wired but tired” states, and slow recovery despite clean labs.

• Key clinical levers:

  • Support NRF2 activation through phytonutrients and restorative lifestyle habits.

  • Reduce inflammasome activity by repairing gut integrity and balancing redox state.

  • Promote resolution through adenosine signaling (rest, parasympathetic activation, magnesium) and Omega-3 fatty acids, including EPA and DHA.

  • Reactivate autophagy and mitophagy with fasting, exercise, and circadian rhythm repair.

  • Rebuild microbial diversity to stabilize the gut-mitochondria axis.

Healing is ultimately about restoring the body’s perception of safety. Every nutritional, behavioral, or environmental intervention is a way of telling the cell: “The danger is over. You can begin again.”

For a deeper understanding

Gut health and chronic disease (Part I): Understanding the connection

Gut health and chronic disease (Part II): Our gut biome’s co-workers and their role in resilience

Gut health as a determinant of mitochondrial function

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Agorastos A., & Chrousos G. P. (2022). The neuroendocrinology of stress: The stress-related continuum of chronic disease development. Molecular Psychiatry, 27, 502–513.

Ai, Y., Wang, H., Liu, L., Qi, Y., Tang, S., Tang, J., & Chen, N. (2023). Purine and purinergic receptors in health and disease. MedComm (2020), 4(5), e359 https://doi.org/10.1002/mco2.359

Guo, Y., Cho, S. W., Saxena, D., & Li, X. (2020). The multifaceted actions of succinate as a signalling transmitter vary with its cellular location. Endocrinology and Metabolism, 35(1),36–43. https://doi.org/10.3803/EnM.2020.35.1.36

Hough, D., Mao, A. R., Aman, M., Lozano, R., Smith-Hicks, C., Martinez-Cerdeno, V., Derby, M., Rome, Z., Malan, N., & Findling, R. L. (2023). Randomized clinical trial of low-dose suramin intravenous infusions for the treatment of autism spectrum disorder. Annals ofGeneral Psychiatry, 22(1),45.https://doi.org/10.1186/s12991-023-00477-8

Huang, Y., Zhou, J., Peng, X., & Liu, X. (2021). From purines to purinergic signalling: Molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6(1),68.https://doi.org/10.1038/s41392-021-00553-z Naviaux, R. K. (2014a). Metabolic features of the cell danger response. Mitochondrion,16,7–17. https://doi.org/10.1016/j.mito.2013.08.006

Lu S., Wei F., & Li G. (2021). The evolution of the concept of stress and the framework of the stress system. Cell Stress, 5, 76–84.

Naviaux, R. K. (2020). Perspective: Cell danger response Biology—The new science that connects environmental health with mitochondria and the rising tide of chronic illness. Mitochondrion, 51,40–45. https://doi.org/10.1016/j.mito.2019.12.005

Naviaux, R. K., Curtis, B., Li, K., Naviaux, J. C., Bright, A. T., Reiner, G. E., Westerfield, M., Goh, S., Alaynick, W. A., Wang, L., Capparelli, E. V., Adams, C., Sun, J., Jain, S., He, F., Arellano, D. A., Mash, L. E., Chukoskie, L., Lincoln, A., & Townsend, J. (2017). Low-dose suramin in autism spectrum disorder: A small, phase I/II, randomized clinical trial. Annals of Clinical and Translational Neurology, 4(7),491–505. https://doi.org/10.1002/acn3.424

Naviaux, R. K., & Naviaux, J. C. (2017a). Antipurinergic therapy for autism: An in-depth review. Mitochondrion. https://doi.org/10.1016/j.mito.2017.12.007

Noushad S. et al. (2021). Physiological biomarkers of chronic stress: A systematic review. International Journal of Health Sciences, 15, 46–53.

Pizzorno J. E., & Murray M. T. (2020). Textbook of Natural Medicine (5th ed., Ch. 136). Elsevier.

Ruscio M. (2023). How to recognize & treat a cell danger response. Retrieved from https://drruscio.com/how-to-treat-cell-danger-response/

Steffan, D., Pezzini, C., Esposito, M., & Franco-Romero, A. (2025). Mitochondrial aging in the CNS: Unravelling implications for neurological health and disease. Biomolecules, 15(9), 1252. https://doi.org/10.3390/biom15091252

Territo, P. R., Ferraris, D., & Kirkwood, C. A. (2021). P2X7 receptors in neurodegeneration. Frontiers in Cellular Neuroscience, 15, Article617036. https://doi.org/10.3389/fncel.2021.617036

Wei, S., Song, X., Mou, Y., Zhou, W., Zhao, T., Li, W., Yang, H., & Chen, J. (2025). New insights into pathogenisis and therapies of P2X7R in Parkinson’s disease. Npj Parkinson's Disease, 11, 108. https://doi.org/10.1038/s41531-025-00980-7

Wu Z., Qu J., Zhang W., & Liu G.-H. (2024). Stress, epigenetics, and aging: Unraveling the intricate crosstalk. Molecular Cell, 84, 34–56.

Xu, X., Pang, Y., & Fan, X. (2025). Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances. Signal Transduction and Targeted Therapy, 10,190. https://doi.org/10.1038/s41392-025-02253-4

Zong, Y., Li, H., Liao, P., Peng, Y., Yu, D., Wang, X., Hou, Y., Ma, C., Tian, M., Chen, T., Zhang, Y., Dong, C., Song, W., Wang, C., Li, C., Du, J., Wang, Q., Hu, S., Wang, T., Zhang, P., Ma, X., & Liu, G. (2024). Mitochondrial dysfunction: Mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9, 124. https://doi.org/10.1038/s41392-024-01839-8

This connection serves as a nutrient-to-energy interface, and when disrupted, it drives dysfunction across multiple organ systems, becoming a significant determinant of both acute and chronic diseases with wide-ranging consequences. Understanding this connection reframes chronic disease as a systems failure rooted in disrupted nutrient processing and energy generation, and it is more than just a research concept. It is emerging as a central framework for understanding energy, resilience, and the origins of chronic disease.

Mitochondria in context

Mitochondria are present in nearly all nucleated cells, with the number of mitochondria proportional to the cell's energy demand. Their abundance reflects energy demand, where muscle cells and neurons contain thousands, and mature red blood cells expel their mitochondria entirely to maximize hemoglobin content. Energy generation is their best-known role, but mitochondria also act as signaling centers, regulate programmed cell death (apoptosis), and integrate nutrient metabolism by oxidizing fatty acids, recycling amino acids, and stabilizing glucose availability. Their ability to function efficiently is contingent upon a healthy gut, which provides both nutrients and regulatory metabolites.

When mitochondria are unhealthy or under stress, it may be felt long before laboratory tests confirm dysfunction. Common symptoms include persistent fatigue, poor stamina, exercise intolerance, muscle weakness or cramping, brain fog, memory issues, headaches, and mood changes. Systemic effects can include blood sugar dysregulation, cold intolerance, unexplained weight changes, and gastrointestinal symptoms such as bloating or poor nutrient absorption. Because mitochondria influence every energy-dependent tissue, dysfunction can also present as cardiovascular complaints (palpitations, exercise-induced discomfort) and heightened inflammatory states (aches, low-grade fevers, immune dysregulation). These nonspecific but cumulative symptoms often represent early signs of impaired mitochondrial performance.

Microbiome influence on mitochondria

The microbiome directly shapes immunity and, through its chemical outputs (metabolites), influences mitochondrial performance. Key beneficial microbes, such as Faecalibacterium prausnitzii, generate butyrate, the primary fuel for our colon cells, which fortifies the intestinal barrier and enhances energy production while mitigating inflammation. Other species contribute acetate and propionate, thereby regulating glucose and lipid metabolism. Meanwhile, Bifidobacterium species support immune tolerance and mucus renewal within the gut lining, which is particularly critical during early life. Akkermansia muciniphila maintains mucus integrity and metabolic balance, whereas expansion of Proteobacteria often signals dysbiosis and endotoxin-driven inflammation.

Microbial fermentation of dietary fiber in the large intestine yields short-chain fatty acids (SCFAs) that not only sustain our gut lining but also optimize mitochondrial efficiency in the liver, skeletal muscle, and brain. Beyond SCFAs, other microbial metabolites, such as bile acids and tryptophan byproducts, act as signaling molecules.

These compounds activate energy-regulating pathways like AMPK (the cell’s energy sensor), PPARs (nuclear receptors that govern fat and glucose metabolism), and FXR (a bile acid receptor that influences mitochondrial stress responses). In doing so, the microbiome fine-tunes how mitochondria balance energy generation, nutrient utilization, and inflammation across tissues. For a deeper dive into the inner workings of our gut microbiome, visit our article on Gut Health and Chronic Disease Part I.

Clinical implications

Communication between the gut and mitochondria relies on a steady flow of immune signals and chemical messages from our microbiomes. These compounds determine whether nutrients are efficiently converted into energy or whether stress and inflammation dominate. The efficiency of mitochondrial energy production depends not only on nutrient intake but also on how those nutrients are processed and delivered by the gut. Microbial metabolites act as key messengers that fine-tune mitochondrial biogenesis, oxidative balance, and nutrient utilization.

When the gut cannot deliver sufficient substrates, the key energy-generating processes (the Krebs cycle and oxidative phosphorylation) falter. Under healthy conditions, mitochondria generate low levels of reactive oxygen species (ROS: chemically reactive byproducts of energy production) that activate antioxidant defenses and promote mitochondrial growth. When systemic inflammation, often triggered by gut permeability or dysfunction, overwhelms this balance, ROS accumulate, the electron transport chain (a chain of proteins that produce energy) becomes impaired, energy declines, and mitochondrial DNA fragments.

The impacts of stressed mitochondria extend across systems. In the cardiovascular system, oxidative stress accelerates gut lining dysfunction and the formation of plaques. In the brain, it contributes to neuronal injury and the progression of Alzheimer’s and Parkinson’s disease. In skeletal muscle, it disrupts insulin signaling and fosters metabolic dysfunction. When mitochondria are impaired or communication fails, energy production drops, oxidative stress rises, and chronic inflammation becomes the prevailing state. All of which are shared hallmarks of metabolic, cardiovascular, neurodegenerative, and immune-mediated diseases.

Measurable markers

Markers of healthy gut-to-mitochondrial communication can be detected through a combination of clinical laboratory tests and advanced functional testing. These tools, when interpreted together, provide a system-level view of how the gut and mitochondria interact in both resilience and disease:

• SCFA levels: stool or plasma analysis for butyrate, acetate, and propionate (e.g. BiomeFx*, GI-MAP* with add-ons).

• Bile acid metabolism: serum or stool bile acid panels, including primary-to-secondary bile acid ratios.

• Tryptophan metabolism: plasma or urine tryptophan-to-kynurenine ratio and indole derivatives, often captured in organic acid testing.

• Organic acid testing (OAT): provides insight into mitochondrial energy output, microbial overgrowth, and nutrient cofactor needs by measuring metabolites in urine.

• Comprehensive stool panels (e.g. GI360*, Gut 360*, GI Effects*): evaluate microbial composition, diversity, inflammation, and fermentation patterns that influence mitochondrial function.

• Circulating mitochondrial DNA (mtDNA): detected in plasma, indicating mitochondrial stress and cellular damage.

• Oxidative stress biomarkers: ratios of reduced-to-oxidized glutathione, F2-isoprostanes, and lipid peroxidation markers.

• Functional mitochondrial testing: high-resolution respirometry measuring ATP output and reserve capacity under stress.

Disease implications

Breakdowns in communication between the gut and mitochondria ripple outward, leading to whole-body dysfunction. The resulting energy deficits, inflammatory cascades, and metabolic disturbances are evident across nearly every domain of chronic disease, influencing how conditions develop and progress.

• Metabolic disorders: Reduced SCFA production weakens mitochondrial energy generation, blunts insulin sensitivity, disrupts blood sugar regulation, and contributes to fatty liver disease

• Cardiovascular system: Microbial byproducts such as trimethylamine N-oxide interfere with the health of blood vessels, making them less flexible and more prone to injury. Mitochondria under stress produce excess reactive oxygen species, which are highly reactive molecules that damage vessel walls and accelerate plaque buildup. Together, these changes raise the risk of heart disease.

• Brain: Mitochondrial stress can be particularly damaging here because mitochondrial respiration (the process of converting nutrients and oxygen into energy) slows down, leaving neurons more fragile. Combined with inflammation triggered by gut permeability, this contributes to the progression of conditions like Parkinson’s and Alzheimer’s disease. In simple terms, when brain cells can’t make enough energy, they struggle to repair themselves and eventually die off.

• Immune system: When fragments of bacteria slip through a weakened gut barrier into the bloodstream, they activate immune defenses. At the same time, stressed mitochondria release reactive oxygen species: chemicals that amplify inflammation. Together, these signals can tip the immune system toward chronic overactivity, increasing the risk of autoimmune conditions.

• Cancer: An unhealthy gut fosters DNA damage and inflammation that support tumor growth. On the contrary, beneficial metabolites like butyrate can help trigger programmed cell death in abnormal cells and support immune defenses against cancer. This duality is tied to the “Warburg effect,” where cancer cells prefer less efficient energy pathways even in oxygen-rich conditions.

Therapeutic and environmental influences

Restoring balance in the connection between our gut and mitochondria requires attention to both targeted therapies and the broader environment in which cells function. Microbiome-directed approaches are among the most promising. Probiotic- and prebiotic-rich foods have been shown to enhance microbial balance, boost short-chain fatty acid production, and reduce systemic inflammation.

Pharmacological agents can also shape this nutrient-to-energy relationship, sometimes beneficially and sometimes with unintended consequences. Metformin, for example, supports mitochondrial oxidative capacity by enhancing the microbiota's ability to produce SCFAs, which helps explain its insulin-sensitizing effects. Statins, widely used to lower cardiovascular risk, alter microbial composition and decrease coenzyme Q10 availability, which may impair mitochondrial respiration in some individuals. Long-term antibiotic use reduces microbial diversity, the production of SCFAs, and disrupts mitochondrial energy metabolism. Certain chemotherapy agents exert direct mitochondrial toxicity, often mediated by their impact on gut microbial communities.

Beyond clinical interventions, environmental and lifestyle factors can shape the resilience of this system. Nutrition remains one of the strongest drivers: diets rich in fiber and plant-based foods encourage the production of microbial metabolites that support mitochondrial biogenesis and efficient energy metabolism, whereas ultra-processed foods blunt these pathways. Physical activity, both endurance and resistance training, enhances microbial diversity, increases the abundance of SCFA-producing bacteria, and stimulates mitochondrial capacity in muscle and other tissues. Sleep and psychological stress also exert powerful influences. Chronic sleep deprivation and ongoing stress weaken the gut barrier, elevate systemic inflammation, and destabilize mitochondrial homeostasis, leaving the body less able to repair and adapt.

Our other microbial ecosystems also contribute to mitochondrial health. Taken together, these therapeutic, environmental, and lifestyle factors suggest that mitochondrial resilience is not determined by a single input, but rather by the ongoing interaction between gut health, systemic microbial communities, and the conditions under which we live.

• The oral microbiome produces inflammatory mediators linked to vascular dysfunction and neurodegeneration. When vascular function is impaired, it contributes to high blood pressure, atherosclerosis, heart disease, stroke, and even cognitive decline.

• The skin microbiome influences immune signaling and oxidative stress. Long-term oxidative stress contributes to inflammation, aging, and chronic diseases such as cardiovascular disease, diabetes, neurodegeneration, and cancer.

• The lung microbiome, when disrupted by infection or pollution, can trigger cytokine-mediated mitochondrial stress in distant organs.

• The vaginal microbiome shapes fertility, pregnancy outcomes, and menopausal health by regulating inflammation and mitochondrial function in reproductive tissues.

• The liver microbiome directly governs hepatocyte mitochondrial metabolism through the gut–liver connection, contributing to the development of fatty liver disease.

• Circadian rhythms, synchronized by daylight, regulate mitochondrial efficiency. Insufficient natural light or excessive artificial light at night disrupts these rhythms, leading to increased oxidative stress.

Supporting this relationship requires careful consideration of interventions, awareness of potential trade-offs, and alignment of daily rhythms with the body’s energy needs. For a deeper understanding of how these microbiomes influence our gut, refer to Gut Health and Chronic Disease Part II.

In conclusion

A disrupted gut-to-mitochondria connection reframes chronic disease as a failure of communication between two essential systems: the microbial networks that process nutrients and the cellular engines that turn them into energy. When this dialogue is intact, the result is efficient metabolism, balanced immunity, and resilience across tissues. When it breaks down, energy falters, inflammation rises, and the pathways of chronic illness accelerate. By recognizing the central role of gut-mitochondria interactions, clinicians and researchers can identify dysfunction earlier, apply targeted testing, and design interventions that restore energy balance at its root. This systems view moves beyond treating symptoms and offers a framework for understanding and addressing the origins of modern chronic disease.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

*Disclaimer: The tests and tools mentioned in this article are provided for educational purposes only. We do not endorse any specific laboratory, company, or testing method, nor have we received compensation or sponsorship for including them. Readers should consult with a qualified healthcare professional before pursuing any diagnostic testing or treatment.

References

Borbolis F, Mytilinaiou E, Palikaras K. The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration. Cells. 2023 Jan 28;12(3):429. doi: 10.3390/cells12030429. PMID: 36766772; PMCID: PMC9913973.

Du, Y.; He, C.; An, Y.; Huang, Y.; Zhang, H.; Fu, W.; Wang, M.; Shan, Z.; Xie, J.; Yang, Y.; et al. The Role of Short Chain Fatty Acids in Inflammation and Body Health. Int. J. Mol.Sci.2024,25,7379. https:// doi.org/10.3390/ijms25137379

Front. Pharmacol. 15:1428242. doi: 10.3389/fphar.2024.1428242

Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021 Feb 11;20:301-319. doi: 10.17179/excli2020-3239. PMID: 33746664; PMCID: PMC7975634.

Haque, P.S., Kapur, N., Barrett, T.A. et al. Mitochondrial function and gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 21, 537–555 (2024). https://doi.org/10.1038/s41575-024-00931-2

Kulkarni H, Gaikwad AB. The mitochondria-gut microbiota crosstalk - A novel frontier in cardiovascular diseases. Eur J Pharmacol. 2025 Jul 5;998:177562. doi: 10.1016/j.ejphar.2025.177562. Epub 2025 Mar 27. PMID: 40157703.

Lin, L., Xiang, S., Chen, Y., Liu, Y., Shen, D., Yu, X. ... Ning, Z. (2024). Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review). Experimental and Therapeutic Medicine, 28, 427. https://doi.org/10.3892/etm.2024.12716

Liu X, Xu M, Wang H, Zhu L. Role and Mechanism of Short-Chain Fatty Acids in Skeletal Muscle Homeostasis and Exercise Performance. Nutrients. 2025 Apr 26;17(9):1463. doi: 10.3390/nu17091463. PMID: 40362771; PMCID: PMC12073122.

Loh, J.S., Mak, W.Q., Tan, L.K.S. et al. Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Sig Transduct Target Ther 9, 37 (2024). https://doi.org/10.1038/s41392-024-01743-1

Shanmugham, M.; Bellanger, S.; Leo, C.H. Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals 2023, 16, 504. https://doi.org/10.3390/ph16040504

Shen, Y., Fan, N., Ma, S.-x., Cheng, X., Yang, X., & Wang, G. (2025). Gut microbiota dysbiosis: Pathogenesis, diseases, prevention, and therapy. Microorganisms, 13(2), 70168. https://doi.org/10.1002/mco2.7016

Warburg, O. (1956). On the origin of cancer cells. Science, 123(3191), 309–314. https://doi.org/10.1126/science.123.3191.309

Wen L, Yang K, Wang J, Zhou H, Ding W. Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine. Front Pharmacol. 2025 Apr 22;16:1574887. doi: 10.3389/fphar.2025.1574887. PMID: 40331200; PMCID: PMC12052897.

Zachos KA, Gamboa JA, Dewji AS, Lee J, Brijbassi S and Andreazza AC (2024), The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease.

Zhang, D., Jian, YP., Zhang, YN. et al. Short-chain fatty acids in diseases. Cell Commun Signal 21, 212 (2023). https://doi.org/10.1186/s12964-023-01219-9

Zhao H, Qiu X, Wang S, Wang Y, Xie L, Xia X, Li W. Multiple pathways through which the gut microbiota regulates neuronal mitochondria constitute another possible direction for depression. Front Microbiol. 2025 Apr 17;16:1578155. doi: 10.3389/fmicb.2025.1578155. PMID: 40313405; PMCID: PMC12043685.

When we talk about gut health, it’s easy to reduce the conversation to a tally of “good” and “bad” bacteria. But the reality is far richer and far more important for understanding health and disease. A key distinction sets the stage: microbiota refers to the living organisms themselves—bacteria, fungi, viruses, archaea, even parasites. Microbiome, on the other hand, includes not only those organisms but also their genetic potential (genes), their chemical fingerprints (metabolites), and the jobs they perform within the body (functions).

This shift in perspective moves us away from a numbers game toward viewing the gut as an ecosystem. Health emerges not from the sheer presence or absence of certain microbes, but from the overall harmony and productivity of that system. Disease, then, is less about invaders and more about lost functions, imbalances, or toxic byproducts. And therapies become not just about wiping out or adding microbes, but about restoring balance at the system level, where resilience truly resides.

Distinct microbial communities populate nearly every surface and cavity of the human body, each with specialized roles in maintaining balance and constant communication with one another. To see this web of influence in action, let’s take a closer look at the hub-and-network dynamics of specific microbiomes and how they shape the gut.

The oral microbiome: gateway to systemic health

Saliva and swallowed bacteria provide a direct route for oral microbes into the gastrointestinal tract, influencing gut composition. Conversely, gut inflammation and systemic immune signals can alter the oral microbial environment, explaining bidirectional links between periodontal disease and gut dysbiosis. For practitioners, this cross-talk underscores the importance of considering oral health when addressing digestive concerns with clients and patients. Our oral microbiome includes hundreds of bacterial species that help regulate the mouth’s pH, begin digestion, and maintain tooth and gum health. Beyond oral health, this community acts as a gateway to systemic health: when balanced, it limits colonization by pathogens; when disrupted, it can seed inflammation elsewhere in the body.

Why it matters: Oral pathogens and chronic inflammation don’t just stay in the mouth. They are swallowed daily and travel to the gut and beyond, altering microbial composition. Chronic oral inflammation also increases systemic inflammatory markers, such as CRP and cytokines, which can increase gut permeability, leading to greater immune activation and increased risk for cardiovascular disease and diabetes. New research also highlights a link to Alzheimer’s, suggesting a direct connection between oral health and brain function.

The vaginal microbiome: hormones and protection

The vaginal microbiome is one of the best examples of microbial specialization. Dominated by Lactobacillus species, it produces lactic acid that maintains a low pH environment, offering protection against pathogens and supporting reproductive health. This balance is dynamic, influenced by hormonal shifts across the lifespan. During reproductive years, Lactobacillus dominance supports fertility and pregnancy outcomes, while menopause reduces glycogen availability in vaginal tissues. In perimenopause and menopause, this shift is significant because it contributes to Genitourinary Syndrome of Menopause (GSM), weakens microbial stability, and increases the risks of inflammation and infection. These microbial dynamics are strongly influenced by hormones and immune status, meaning that disturbances in gut ecology can directly impact vaginal balance.

Why it matters: Disruptions in the vaginal microbiome increase risk of bacterial vaginosis, preterm birth, and infertility. Imbalances in this area are often overlooked in broader discussions of microbiome science.

The skin microbiome: where inside meets outside

The skin microbiome illustrates how external and internal systems meet. It produces antimicrobial compounds, supports wound healing, and trains the immune system. Yet, it is also sensitive to gut-derived metabolites and inflammatory signals. Gut dysbiosis can exacerbate skin conditions, including eczema and acne. In practice, this suggests that persistent dermatological complaints may warrant an assessment of gut health and diet as part of a broader strategy.

Why it matters: Skin dysbiosis reflects immune dysfunction that often originates in gut imbalance, but it also works in reverse. Chronic skin inflammation increases systemic cytokine levels, which stress the gut barriers and alter microbial communities. This bi-directional loop helps explain why many people with eczema or psoriasis also have GI complaints or autoimmune comorbidities.

The lung microbiome: gut-lung axis

The lung microbiome, once assumed sterile, is now recognized as a low-biomass but active community. It interacts with the gut via the gut-lung axis, where microbial metabolites and immune signals travel between the two systems. A balanced lung microbiome appears to support immune readiness and tolerance, while disruption is increasingly associated with asthma, COPD, and chronic infections. Clinically, this means that respiratory and digestive symptoms may be more effectively addressed together rather than in isolation.

Why it matters: In asthma, airway inflammation alters immune signaling. Those same immune pathways, especially Th2 skewing and cytokine release, influence gut immunity. Studies show that asthmatic inflammation can alter the gut microbial balance, reducing the number of beneficial species and weakening tolerance. That, in turn, heightens the risk of allergic disease, metabolic dysfunction, and other chronic inflammatory conditions.

Other biomes: liver, bladder, brain

Even organs not traditionally considered microbially active exhibit microbial influences. The liver, pancreas, and gallbladder are indirectly shaped by gut-derived metabolites through portal circulation, which impacts energy metabolism and detoxification. The bladder harbors a low-biomass microbiome that contributes to urinary tract health, influencing susceptibility to infection and chronic irritation.

The brain itself does not have a resident microbiome, but it is deeply connected through the gut-brain axis, receiving constant input from gut microbial signals that affect neurotransmission, stress responses, and cognition. The gut-brain axis (GBA) is a central component of the body’s microbial network and illustrates how gut health impacts not only digestion and immunity but also mood, cognition, stress responses, and sleep. Microbial metabolites, neurotransmitter precursors, and immune signals travel from the gut to the brain, while the brain regulates gut function through hormones and autonomic pathways. By incorporating bidirectional communication into the discussion of microbial networks, we can gain a deeper understanding of the broader significance of gut health and its central role in whole-body resilience.

Of course, the gut-brain axis

By now, most people have at least heard of the GBA. It is often mentioned in conversations tied to mood, stress, or digestion. What it really describes, however, is a sophisticated, two-way communication system between the gut microbiome and the brain. Signals travel along multiple channels. The vagus nerve provides a direct neural line, carrying information from the gut to the brain in real time. Hormones add another layer: gut microbes help shape cortisol and gut peptides that regulate stress, appetite, and mood. The immune system is also deeply involved, as microbial metabolites influence the release of cytokines that can alter brain function and behavior.

When this system is in balance, it supports mental clarity, emotional regulation, and resilience. When it’s disrupted through dysbiosis or imbalance in the gut community, the ripple effects can show up in ways that look very different on the surface: depression, anxiety, autism spectrum disorder, even neurodegenerative conditions like Alzheimer’s and Parkinson’s.

Why it matters: These body-wide microbial systems remind us that health is a networked property. The gut may be the hub, but each microbial community contributes unique and essential functions to overall resilience.

Shared microbial language

Despite their different locations and roles, the body’s microbiomes communicate in a common biochemical ‘language’ to sustain health. They metabolize dietary compounds into short-chain fatty acids (SCFAs) and other metabolites that fuel colon cells, shape immune tolerance, and influence energy metabolism. They also provide colonization resistance, producing antimicrobial compounds that keep harmful organisms in check.

This shared set of functions is what links the oral, skin, lung, vaginal, and other microbiomes back to the gut. Signals from one community travel into the others through circulation, immune pathways, and the nervous system. In this way, the body’s microbial ecosystems act less like isolated neighborhoods and more like an interconnected network, each speaking the same language, each influencing the others.

Why our gut matters the most

Among all these interconnected microbial communities, the gut stands out as the most dense, diverse, and influential hub. It not only carries the richest microbial population but also sits at the crossroads of digestion, metabolism, immunity, and brain signaling. Colonization begins at birth, shaped by delivery mode, breastfeeding, antibiotic exposure, and environment. Vaginal delivery and breastfeeding promote colonization with Lactobacillus and Bifidobacterium, while diverse exposures in early childhood expand microbial richness. In contrast, cesarean delivery tends to favor colonization by skin-associated and environmental microbes, often reducing microbial diversity and increasing the risk of allergies, autoimmune disorders, and metabolic diseases later in life. An overly sanitized environment can also limit microbial diversity and increase the risk of immune-mediated disease.

The gut microbiome contributes directly to digestion and metabolism by fermenting fiber into SCFAs, regulating nutrient absorption, and supporting systemic energy balance. It communicates with mitochondria, influences immune training, and constantly signals to the brain through neural, endocrine, and immune pathways. Keystone species are particularly important within the gut microbiome, exerting influence beyond their relative abundance. For example:

• Bacteroides and Prevotella both play central roles in breaking down complex carbohydrates and fibers.

• Faecalibacterium prausnitzii is a major producer of butyrate, which fuels colon cells, maintains the gut barrier, and reduces inflammation.

• Akkermansia muciniphila resides in the mucus lining of the gut, strengthening this barrier and supporting metabolic health.

• Bifidobacterium species are among the earliest colonizers of the infant gut, feeding on human milk oligosaccharides, and throughout life, they continue to support the integrity of the gut barrier and immune responses.

• Lactobacillus species help maintain mucosal pH through lactic acid production, inhibiting pathogens and promoting balance.

• Roseburia and Ruminococcus degrade complex fibers and generate beneficial SCFAs. When these species decline, the result is not only local inflammation but also systemic consequences that extend to the lungs, skin, and oral cavity.

In conclusion

The future of microbiome science lies in personalization and integration. Advances in sequencing now make it possible to map microbial “fingerprints,” enabling tailored diets and targeted interventions. The “old friends’ hypothesis” reminds us that humans co-evolved with environmental microbes that trained immune tolerance, organisms largely missing from modern life. Reintroducing their signals, whether through diet, lifestyle, or supplementation, may help restore balance.

Most importantly, the gut must be understood in context. It is a powerful hub, but it cannot be separated from other microbial communities. Oral, vaginal, skin, lung, and other biomes each bring unique roles, and their constant cross-talk with the gut ensures that an imbalance in one reverberates across the whole. For practitioners and health seekers, the takeaway is actionable: gut health matters, but only as part of a whole-body biome network. Recognizing this interconnectedness shifts both science and practice toward true whole-person care.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., & Aadil, R. M. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, Article 999001. https://doi.org/10.3389/fmicb.2022.999001

American Society for Microbiology. (2023). Gut microbiome communication: The gut-organ axis. https://asm.org/articles/2023/january/gut-microbiome-communication-the-gut-organ-axis

DeLeon, O., & Chang, E. B. (2025). Assessing the health of the gut microbial organ: Why and how? Journal of Clinical Investigation, 135(11), Article e184313. https://doi.org/10.1172/JCI184313

Grech, A., Collins, C. E., Holmes, A., Lal, R., Duncanson, K., Taylor, R., & Gordon, A. (2021). Maternal exposures and the infant gut microbiome: A systematic review with meta-analysis. Gut Microbes, 13(1), Article 1897210. https://doi.org/10.1080/19490976.2021.1897210

Hou, K., Wu, Z. X., Chen, X. Y., Wang, W., Zhang, M., Guo, Z., et al. (2022). Microbiota in health and diseases. Signal Transduction and Targeted Therapy, 7, Article 135. https://doi.org/10.1038/s41392-022-00974-4

McBurney, M. I., Davis, C., Fraser, C. M., Schneeman, B. O., Huttenhower, C., Verbeke, K., Walter, J., & Latulippe, M. E. (2019). Establishing what constitutes a healthy human gut microbiome: State of the science, regulatory considerations, and future directions. The Journal of Nutrition, 149(11), 1881–1895. https://doi.org/10.1093/jn/nxz154

Pantazi, A. C., Balasa, A. L., Mihai, C. M., Chisnoiu, T., Lupu, V. V., Kassim, M. A. K., Mihai, L., Frecus, C. E., Chirila, S. I., Lupu, A., Andrusca, A., Ionescu, C., Cuzic, V., & Cambrea, S. C. (2023). Development of gut microbiota in the first 1000 days after birth and potential interventions. Nutrients, 15(16), Article 3647. https://doi.org/10.3390/nu15163647

Salvadori, M., & Rosso, G. (2024). Update on the gut microbiome in health and diseases. World Journal of Methodology, 14(1), Article 89196. https://doi.org/10.5662/wjm.v14.i1.89196

Van Hul, M., Cani, P. D., Petitfils, C., De Vos, W. M., Tilg, H., & El-Omar, E. M. (2024). What defines a healthy gut microbiome? Gut, 73(11), 1893–1908. https://doi.org/10.1136/gutjnl-2024-333378

Yao, Y., Cai, X., Ye, Y., Wang, F., Chen, F., & Zheng, C. (2021). The role of microbiota in infant health: From early life to adulthood. Frontiers in Immunology, 12, Article 708472. https://doi.org/10.3389/fimmu.2021.708472

Zhu, S., Jiang, Y., Xu, K., Wang, Y., Zhang, W., Ruan, B., Ma, C., Liu, B., Wang, G., Zhang, S., Liu, Z., Fu, T., Xie, A., & Liu, C. (2020). The progress of gut microbiome research related to brain disorders. Journal of Neuroinflammation, 17, Article 25. https://doi.org/10.1186/s12974-020-1705-2

Of all the health buzzwords circulating today, none attracts more interest (or more misinformation) than “gut health." The term appears everywhere: in journal articles, patient consultations, supplement ads, and wellness blogs. Yet unlike cholesterol, blood pressure, or HbA1c, there is no single biomarker that can declare a gut ‘healthy’ or ‘unhealthy.’ That is because the gut isn’t just one organ. It is a living system: a gastrointestinal tract lined by barrier tissues, powered by enzymes, and inhabited by trillions of microbes. It is an immune ecosystem that trains tolerance and defense, and a neural network that constantly communicates with our brain. When we discuss gut health, what we really mean is how well these interwoven systems adapt and remain resilient in the face of stress. A healthy gut efficiently regulates digestion, immunity, metabolism, and even our mood. When these systems start to fail, the effects ripple outward, shaping risks for metabolic, autoimmune, and neurocognitive disease.

Why is defining gut health so challenging?

Unlike diabetes, which can be defined by blood glucose levels, or hypertension by systolic/diastolic cutoffs, gut health lacks a universally accepted diagnostic test. Instead, researchers and clinicians must rely on proxies:

• Symptoms such as bloating, diarrhea, or pain are useful but subjective, and are not always correlated with dysfunction.

• Inflammatory markers like calprotectin or C-reactive protein are valuable but incomplete on their own.

• Microbiome sequencing (mapping) is a promising science, but still lacks standardized clinical interpretation.

Each measure offers part of the overall picture, but no single measure tells the whole story. This is why gut health is best understood as a system property, the emergent outcome of multiple and interconnected physiological domains working in synchrony. To organize this complexity, researchers have outlined four key pillars that, together, can help us better understand gut health. Each can be assessed as a measurable biomarker, and when disrupted, each may drive distinct clinical consequences.

The four pillars of gut health

1. Digestion and absorption

The gut’s foundational task is efficient digestion and nutrient absorption. Enzymes, bile salts, and epithelial transporters convert food into usable molecules. Meanwhile, commensal microbes ferment fibers into short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. These SCFAs regulate sugar and fat metabolism, fuel the cells of our colon, and exert anti-inflammatory effects. Microbes also synthesize key vitamins (K, and B group) and modulate mineral uptake.

Lab markers used to measure efficient digestion and nutrient absorption:

• Stool elastase for pancreatic function, fecal fat, breath tests for malabsorption.

• Serum nutrient panels: iron, B12, folate, vitamin D.

• SCFAs levels in stool or plasma.

If left unchecked, malabsorption can lead to digestive symptoms, as well as micronutrient deficiencies, anemia, fatigue, an increased risk of osteoporosis, and impaired metabolic regulation. Over time, this can weaken immune function and reduce resilience to stress.

2. Intestinal barrier integrity

The intestinal barrier is a selective gatekeeper. It is porous enough to absorb nutrients, impermeable enough to block pathogens and toxins. It is composed of epithelial cells sealed by tight junctions, mucus, antimicrobial peptides, and secretory IgA. Beyond serving as a physical wall, this barrier actively communicates with the immune and nervous systems, shaping systemic inflammation and overall health.

Lab markers used to measure effective intestinal barrier integrity:

• Lactose-mannitol permeability tests.

• Zonulin levels (still debated but commonly referenced).

• Calprotectin or LPS-binding protein as indirect signals of inflammation or translocation.

Barrier dysfunction, also known more generically as ‘leaky gut,’ allows bacterial products into circulation, triggering systemic inflammation. This state has been linked to food sensitivities, autoimmune disease, metabolic disorders, and neuroinflammation. Stress, alcohol, NSAIDs, and poor diet are common disruptors.

3. Microbiota balance

The gut microbiome is an ecosystem of bacteria, fungi, viruses, and archaea. A healthy microbiota is diverse, stable, and functionally redundant, traits that create resilience against infection, antibiotics, and dietary shifts. Its influence now extends far beyond digestion, with research linking microbial composition to immunity, mood, metabolism, and even chronic disease.

Lab markers used to measure gut microbiome balance:

• Sequencing-based diversity indices (alpha and beta diversity).

• Relative abundance of beneficial or pathogenic taxa.

• Stool organic acids and metabolomics for functional outputs.

Dysbiosis, the loss of beneficial species or overgrowth of pathobionts, has been associated with obesity, type 2 diabetes, inflammatory bowel disease, and depression. Low diversity also reduces ecosystem resilience, leaving the host more vulnerable to infections and chronic disease.

4. Immune and hormonal function

About 70% of our body’s immune system lives in the gut. This is where immune cells learn to make choices: tolerate food and friendly microbes while staying ready to attack real threats. If that training goes off track, the system can become over-reactive or sluggish, leading to widespread problems. The gut also has its own nervous system, often referred to as the “second brain.” With hundreds of millions of neurons, it runs digestion behind the scenes but also sends constant updates to the brain through the vagus nerve. This back-and-forth shapes how we process stress, how our gut moves food along, and even how we feel emotionally. Gut microbes play an active role in this conversation, producing the majority of the chemical messengers the brain uses, including serotonin, dopamine, and GABA. It regulates motility locally, but also influences mood, focus, and resilience through the gut-brain axis.

Lab markers used to measure efficient immune and hormonal function:

• Secretory IgA in stool for first-line immune defense.

• Inflammatory markers like CRP, IL-6, or TNF-α.

• Neurotransmitter metabolites (serotonin, dopamine, gamma-aminobutyric acid (GABA)) in urine or plasma.

When this gut-immune-brain network is disrupted, the results aren’t confined to digestion. Chronic low-grade inflammation, mood disorders such as anxiety or depression, reduced mental clarity, and even links to neurodegenerative disease can emerge.

Why gut health matters to whole-person health

Taken together, these four pillars position the gut as a central regulatory hub. When one pillar falters, the disturbance rarely stays local; it reverberates through the entire system. For example, the following all contribute to obesity and diabetes:

• Disrupted SCFA production

• Dysbiosis

• Barrier dysfunction

Further, a compromised intestinal barrier, paired with impaired microbial training of the immune system, has been implicated in:

• Autoimmune diseases like rheumatoid arthritis

• Allergic diseases

Breakdowns in the gut-brain communication and altered neurotransmitter production are increasingly recognized as drivers of:

• Anxiety

• Depression

• Other mental health disorders

In short, gut health is not simply about gastrointestinal comfort. For practitioners, it represents a foundation of systemic resilience, one that underpins disease prevention, cognitive performance, and long-term vitality. For practitioners and health seekers alike, this means gut health should be evaluated not through a single test or symptom, but through a constellation of markers, lifestyle factors, and functional assessments. Clinical tools, such as stool form, SCFA levels, microbial diversity, and inflammatory markers, provide useful signals; however, they must be interpreted in conjunction with one another, and clinicians must triangulate across multiple domains, including patient symptoms, lifestyle context, and functional testing.

P.S. The future of gut health is rapidly evolving, with personalized nutrition on the horizon, where diets and synbiotics can be tailored to each individual’s microbiome and health goals. Innovative therapies are emerging that may extend far beyond digestion, addressing systemic conditions through gut-based interventions. Yet even as science advances, everyday choices remain the most powerful levers: dietary diversity, fiber, and polyphenol intake, microbial exposure, stress management, and the mindful use of probiotics or fermented foods. These practices not only alleviate digestive discomfort but also promote whole-person health and enhance performance. Yet the gut does not act alone. Its influence depends on constant cross-talk with other microbial communities in the mouth, lungs, skin, and beyond.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Bischoff SC. 'Gut health': a new objective in medicine? BMC Med. 2011 Mar 14;9:24. doi: 10.1186/1741-7015-9-24. PMID: 21401922; PMCID: PMC3065426.

Brennan AM. Development of synthetic biotics as treatment for human diseases. Synth Biol (Oxf). 2022 Jan 31;7(1):ysac001. doi: 10.1093/synbio/ysac001. PMID: 35350191; PMCID: PMC8944296.

Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019 Aug;68(8):1516-1526. doi: 10.1136/gutjnl-2019-318427. Epub 2019 May 10. PMID: 31076401; PMCID: PMC6790068.

Cha RR, Sonu I. Fecal microbiota transplantation: present and future. Clin Endosc. 2025 May;58(3):352-359. doi: 10.5946/ce.2024.270. Epub 2025 Mar 25. PMID: 40468650; PMCID: PMC12138360.

Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024 Mar;19(2):275-293. doi: 10.1007/s11739-023-03374-w. Epub 2023 Jul 28. PMID: 37505311; PMCID: PMC10954893.

Dowling LR, Strazzari MR, Keely S, Kaiko GE. Enteric nervous system and intestinal epithelial regulation of the gut-brain axis. J Allergy Clin Immunol. 2022 Sep;150(3):513-522. doi: 10.1016/j.jaci.2022.07.015. PMID: 36075637.

Sadhu S, Paul T, Yadav N. Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study. Arch Microbiol. 2025 Aug 6;207(9):213. doi: 10.1007/s00203-025-04417-w. PMID: 40767874; PMCID: PMC12328466.

Wang LY, He LH, Xu LJ, Li SB. Short-chain fatty acids: bridges between diet, gut microbiota, and health. J Gastroenterol Hepatol. 2024 Sep;39(9):1728-1736. doi: 10.1111/jgh.16619. Epub 2024 May 23. PMID: 38780349.

How it works

Beta-alanine is a non-proteogenic amino acid, meaning it is not incorporated into a complete protein, and plays a critical role in exercise physiology. Naturally synthesized in the liver and found in foods like poultry and meat, its primary function lies in serving as a precursor to carnosine, a dipeptide that buffers hydrogen ions (H⁺) in muscle cells during exercise. By increasing intramuscular carnosine concentration, beta-alanine helps athletes delay fatigue and sustain high-intensity efforts, making it a compelling ergogenic aid. By increasing intramuscular carnosine concentration, beta-alanine helps athletes delay fatigue and sustain high-intensity efforts, making it a compelling ergogenic aid.

During short bursts of high-intensity activity, the body relies heavily on anaerobic glycolysis to rapidly produce adenosine triphosphate (ATP). This process leads to a buildup of hydrogen ions, contributing to a decrease in muscle pH, commonly referred to as muscle acidosis. This acidic environment disrupts key processes involved in energy production and muscle contraction. It inhibits key enzymes and phosphocreatine resynthesis, ultimately impairing muscular force and shortening the time to fatigue. Elevated H⁺ levels are also associated with the ‘burning’ sensation that limits an athlete’s willingness or ability to sustain effort. Carnosine, synthesized from beta-alanine and histidine, helps buffer these hydrogen ions, thereby stabilizing pH within muscle tissue and preserving efficient muscle contraction function.

Through consistent supplementation, typically ranging from 3.2 to 6.4 grams per day, muscle carnosine levels can increase significantly, often by 40% to 80%, depending on the protocol and individual response. This buffering capacity translates to improved performance in high-intensity efforts lasting approximately 30 seconds to 10 minutes, a window in which hydrogen ion accumulation is most physiologically limiting.

Performance benefits

Beta-alanine’s ergogenic benefits have been consistently demonstrated in activities where acidosis is a limiting factor. For instance, supplementation has been shown to improve time to exhaustion (TTE), anaerobic power output, and total work performed across a range of sports and protocols. In competitive runners, a 6.5% increase in TTE was observed after 28 days of beta-alanine use, with only minimal gains seen in the placebo group (Marko et al., 2025). Similarly, elite cyclists completing a 7-day high-dose regimen improved their uphill time trial performance without adverse effects, underscoring its potential in both anaerobic and mixed-mode sports.

A recent meta-analysis found the most significant improvements in exercising lasting 4-10 minutes, where beta-alanine enhanced both maximal effort capacity and time-to-completion outcomes. These effects were consistent even at relatively short supplementation periods, provided dosing was maintained daily.

Limitations and safety

While beta-alanine is effective in buffering hydrogen ions during intense activity, its benefits are more limited in prolonged aerobic efforts or efforts lasting less than 30 seconds. Notably, research has shown minimal to no improvement in VO₂max or longer-duration endurance tasks. Likewise, its impact on body composition remains unclear. Despite some isolated studies reporting gains in lean mass when combined with high-intensity training, the broader body of evidence does not support consistent changes in fat mass or overall body weight.

The most common side effect is paresthesia, a temporary tingling sensation typically felt in the face, arms, and torso. This is dose-dependent and can be minimized by using divided doses or sustained-release formulations. No serious health risks have been reported in healthy populations when dosing protocols are followed.

Practical applications for athletes and coaches

For athletic or performance-focused clients, beta-alanine offers a well-tolerated and evidence-backed way to enhance performance in high-intensity efforts. It is particularly well-suited for clients engaging in sports that involve sprinting, repeated intervals, or power endurance efforts, such as track athletes, CrossFit competitors, rowers, and cyclists. However, because benefits hinge on increased muscle carnosine levels over time, beta-alanine must be taken daily, not just pre-workout.

For general health clients or those focused on fat loss or long-distance endurance, beta-alanine may not offer significant benefit and is not worth the investment. However, for serious recreational or competitive athletes, it can extend time to fatigue, improve training quality, and help push performance ceilings, especially when paired with a well-structured program.

If you enjoyed this article, please consider leaving a like on your way out, as it’s one of the quickest and cheapest ways to support my work. In advance, I am incredibly grateful. If you found the information useful, I’d love to hear in the comments!

Leave a comment

References

Antonio, J., Pereira, F., Curtis, J., Rojas, J., & Evans, C. (2024). The Top 5 Can't-Miss Sport Supplements. Nutrients, 16(19), 3247. https://doi.org/10.3390/nu16193247

Georgiou, G. D., Antoniou, K., Antoniou, S., Michelekaki, E. A., Zare, R., Ali Redha, A., Prokopidis, K., Christodoulides, E., & Clifford, T. (2024). Effect of Beta-Alanine Supplementation on Maximal Intensity Exercise in Trained Young Male Individuals: A Systematic Review and Meta-Analysis. International journal of sport nutrition and exercise metabolism, 34(6), 397–412. https://doi.org/10.1123/ijsnem.2024-0027

Marko, D., Snarr, R. L., Bahenský, P., Bunc, V., Krajcigr, M., & Malý, T. (2025). Beta-alanine supplementation improves time to exhaustion, but not aerobic capacity, in competitive middle- and long-distance runners. Journal of the International Society of Sports Nutrition, 22(1). https://doi.org/10.1080/15502783.2025.2521336

Pérez-Piñero, S., Ramos-Campo, D. J., López-Román, F. J., Ortolano, R., Torregrosa-García, A., Luque-Rubia, A. J., Ibáñez-Soroa, N., Andreu-Caravaca, L., & Ávila-Gandía, V. (2024). Effect of high-dose β-Alanine supplementation on uphill cycling performance in World Tour cyclists: A randomised controlled trial. PloS one, 19(9), e0309404. https://doi.org/10.1371/journal.pone.0309404

Diagnosis and symptoms

The diagnostic criteria for PCOS reflect the diversity of symptoms. The widely adopted Rotterdam criteria require the presence of any two out of three features: ovulatory dysfunction (e.g., infrequent or absent ovulation), clinical or biochemical signs of hyperandrogenism, and polycystic ovarian morphology on ultrasound. This broad definition acknowledges that a woman can have polycystic ovaries without having PCOS, and that not all cases involve all three characteristics. Further complicating the picture are the four phenotypes of PCOS, ranging from the classic form that includes all three criteria to less metabolically active versions without signs of hyperandrogenism. These symptoms vary in both their appearance and disease severity, particularly in the degree of insulin resistance.

At the core of PCOS is a breakdown of hormonal and metabolic regulation. Hyperandrogenism, excess male-pattern hormones such as testosterone and DHEAS, is a defining feature and the primary driver of many visible symptoms, including unwanted facial and body hair, cystic acne and thinning of scalp hair. These symptoms, though often minimized, have a significant psychosocial impact and are directly linked to hormonal imbalances originating in the ovaries and adrenal glands. Ovarian theca cells, stimulated excessively by luteinizing hormone and amplified by hyperinsulinemia, overproduce male hormones that disrupt follicle maturation and ovulation. Compounding the issue is a decrease in sex hormone-binding globulin (SHBG), which is suppressed by insulin and leaves more free testosterone in circulation. The result is a vicious cycle of reproductive dysfunction and visible androgen excess.

Long-term disease implications

These surface-level signs are often the first reason women seek help, but the underlying pathology runs much deeper. PCOS is strongly associated with insulin resistance, independent of weight. Up to 70% of lean women and 95% of those with obesity who have PCOS also exhibit insulin resistance. This metabolic disruption places women at significantly higher risk for type 2 diabetes, hypertension, dyslipidemia (obesity), and cardiovascular disease. Studies show that many women with PCOS will develop diabetes by age 40, and they also face elevated long-term risks for endometrial cancer due to chronic anovulation and unopposed estrogen exposure. In addition to disease consequences, PCOS is increasingly recognized as a condition with chronic low-grade inflammation. Elevated markers such as C-reactive protein (CRP), TNF-α, IL-6 (inflammatory markers) are common, particularly among women with obesity, though lean women are not exempt. These inflammatory pathways are now being implicated in both insulin resistance and ovarian dysfunction, contributing to the systemic nature of the disorder.

Lifestyle and non-pharma treatments

Treatment for PCOS must be multi-dimensional, yet the standard of care still too often defaults to medicinal treatment of symptoms: oral contraceptives for menstrual regulation, metformin for insulin resistance, and spironolactone or other anti-androgens for hair growth. While these may play a role in advanced cases, the international guidelines increasingly recognize that lifestyle interventions should be the first-line therapy, particularly for newly diagnosed or milder symptoms.

Dietary approaches have shown significant promise in mitigating both metabolic and reproductive symptoms of PCOS. Low glycemic index (GI) diets, Mediterranean-style eating patterns, ketogenic diets, and anti-inflammatory diets rich in fiber and omega-3s have all demonstrated improvements in insulin sensitivity, testosterone levels, and ovulatory function, even without weight loss. Nutraceuticals such as inositol, vitamin D, magnesium, zinc, and N-acetylcysteine have been shown to reduce insulin resistance, regulate ovulation, and lower systemic inflammation, offering a more targeted and potentially better-tolerated option than pharmaceuticals for many women.

Movement, too, plays a central role. A combination of aerobic and resistance training improves insulin action, reduces visceral adiposity, and enhances fertility outcomes. These benefits appear to be independent of BMI, highlighting the need to move away from the “just lose weight” narrative that dominates so much of the clinical dialogue around PCOS.

Sleep hygiene, stress reduction, and psychological support are also critical but underutilized components of care. Women with PCOS experience higher rates of anxiety, depression, disordered eating, and poor body image, all of which can further dysregulate the HPA axis and worsen hormonal symptoms. Mind-body interventions such as yoga, mindfulness, cognitive behavioral therapy, and even acupuncture have shown preliminary efficacy in improving mental well-being and hormone regulation.

In conclusion

In sum, PCOS is not a one-system problem; it is a full-body, full-spectrum disorder. While pharmaceutical tools have their place, especially in later-stage or treatment-resistant cases, a growing body of evidence supports the use of comprehensive, individualized, lifestyle-first care, emphasizing anti-inflammatory nutrition, movement, targeted supplementation, and stress reduction, as the true front line in managing and potentially reversing the trajectory of this condition. It’s time to stop asking women to “just lose weight” and start addressing the hormonal, metabolic, and inflammatory terrain that underlies PCOS. When we shift our approach from reactive symptom control to systems-level restoration, we don’t just manage PCOS; we change its course.

If you enjoyed this article, please consider leaving a like on your way out, as it’s one of the quickest and cheapest ways to support my work. In advance, I am incredibly grateful. If you found the information useful, I’d love to hear in the comments!

Leave a comment

References

Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., Rao, V., Mousa, A., Alesi, S., & Moran, L. (2023). Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity. BMC endocrine disorders, 23(1), 14. https://doi.org/10.1186/s12902-022-01208-y

Gasieva, D. M., Sheremetyeva, E. V., Kalashnikova, M. F., Dzgoeva, F. K., & Alborova, E. T. (2024). Problemy endokrinologii, 70(4), 103–113. https://doi.org/10.14341/probl13400

Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025). The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients, 17(2), 310. https://doi.org/10.3390/nu17020310

Johnson, C., Garipoğlu, G., Jeanes, Y., Frontino, G., & Costabile, A. (2025). The Role of Diet, Glycaemic Index and Glucose Control in Polycystic Ovary Syndrome (PCOS) Management and Mechanisms of Progression. Current nutrition reports, 14(1), 8. https://doi.org/10.1007/s13668-024-00601-4

Stańczak, N. A., Grywalska, E., & Dudzińska, E. (2024). The latest reports and treatment methods on polycystic ovary syndrome. Annals of medicine, 56(1), 2357737. https://doi.org/10.1080/07853890.2024.2357737

We also looked at how symptoms tend to cluster by severity, ranging from mild sugar cravings and bloating to more entrenched patterns like recurrent infections, fatigue, or skin issues. The key takeaway: Candida reflects a deeper imbalance in the body’s ecosystem.

So now let’s talk about how to recognize its presence and what to do about it.

Yeast overgrowth is often missed because it doesn’t always look like a fungal infection. It can show up in subtle, seemingly disconnected ways until you step back and see the pattern. As discussed in Part 1, symptoms exist along a spectrum, from mild co-factor to systemic disruptor. Below is a framework to help you choose a starting point based on what your body is currently telling you.

Mild imbalance: early clues and gentle course correction

At this level, yeast overgrowth is a co-factor, not a central driver, and you may experience symptoms such as sugar cravings, mild brain fog, or bloating; however, these symptoms are sporadic and manageable. Your system is mostly compensating, but minor signs suggest that your internal terrain is shifting.

✅ Treatment goal: Shift the terrain back to balance before things progress. At this stage, consistency wins over intensity

Try this approach:

• Reduce sugar and processed carbs for 2–4 weeks to slow fungal fuel.

• Prioritize fiber and polyphenols. Add to your diet: flax, chia, Jerusalem artichoke, berries, olive oil, green tea, and rosemary.

• Support detox organs. Ensure daily elimination, hydrate well, and include foods that support the liver (like cruciferous veggies and dandelion tea).

• Balance your stress load. High cortisol directly weakens mucosal immunity, so adaptogens, breathwork, and sleep matter here.

Moderate overgrowth: recurring disruptions that won’t quit

Here, Candida overgrowth is likely a primary disruptor, and symptoms may include fatigue, recurring vaginitis, mood swings, and digestive stress, often chronic or cyclic in nature. Maybe you’ve suspected yeast at some point but don’t know a way forward.

✅ Treatment goal: Starve the yeast, support the host, and build resilience from the inside out. This stage may require 4–6 weeks of focus, followed by a rebuilding phase.

Try this approach:

• Remove top Candida feeders temporarily: sugar, alcohol, refined carbs, gluten, and fermented foods.

• Introduce antifungal botanicals like berberine, oregano oil, or pau d’arco (work with a practitioner to rotate them).

• Rebuild the gut lining with glutamine, zinc carnosine, or soothing demulcents like marshmallow root.

• Repopulate with targeted probiotics such as Saccharomyces boulardii, which competes with Candida and supports microbial diversity.

Systemic overgrowth: everything feels off

At this stage, overgrowth is likely entrenched and systemic, impacting digestion, cognition, mood, skin, and hormone function. Immune evasion is likely contributing to the persistence or recurrence of symptoms. Candida has likely formed protective biofilms, embedded in your tissues, and may be benefiting from broader terrain disruptors like mold exposure, heavy metals, or estrogen dominance.

✅ Treatment goal: Break biofilms, repair the gut lining, and rebuild terrain from the ground up. Expect a slower, more layered process around 8-12 weeks that supports full-body recovery.

Try this approach (ideally with guidance):

• Rotate strong antifungal herbs like neem, caprylic acid, and undecylenic acid, combined with biofilm disruptors like NAC.

• Eliminate high-reactivity foods short term (gluten, dairy, corn, soy, alcohol) to calm inflammation and reduce yeast’s fuel.

• Screen for deeper terrain issues like mold, mycotoxins, chronic stressors, or chemical sensitivity.

• Rebuild post-protocol with fermented foods, gentle adaptogens, nutrient-dense meals, and broad-spectrum probiotics.

Some people experience fatigue, headaches, irritability, or worsened symptoms when they start an antifungal protocol. While sometimes called “die-off,” this can also be a sign that drainage pathways (liver, lymph, bowels) are overwhelmed. Instead of pushing through, pause and support detox routes. More isn't always better; Candida healing requires pacing.

Next Steps

I’ve created a private symptom mapping checklist that mirrors what I use with clients. It helps you connect seemingly unrelated issues and start building a targeted support plan. If you’re interested in the checklist, message me directly, and I’ll send it your way.

If you enjoyed this article, please consider leaving a like on your way out, as it’s one of the quickest and cheapest ways to support my work. In advance, I am incredibly grateful. If you found the information useful, I’d love to hear in the comments!

Leave a comment

References

Faustino, M., Ferreira, C. M. H., Pereira, A. M., & Carvalho, A. P. (2025). Candida albicans: the current status regarding vaginal infections. Applied microbiology and biotechnology, 109(1), 91. https://doi.org/10.1007/s00253-025-13478-2

Jawhara S. (2023). Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection. Microorganisms, 11(6), 1556. https://doi.org/10.3390/microorganisms11061556

Kaur, J., & Nobile, C. J. (2023). Antifungal drug-resistance mechanisms in Candida biofilms. Current opinion in microbiology, 71, 102237. https://doi.org/10.1016/j.mib.2022.102237

Nobile, C. J., & Johnson, A. D. (2015). Candida albicans Biofilms and Human Disease. Annual review of microbiology, 69, 71–92. https://doi.org/10.1146/annurev-micro-091014-104330

Alright. Let’s get into it.

As our understanding of microbial ecology evolves, so too does our recognition of bacteria and fungi’s role in gut barrier dysfunction, immune dysregulation, and chronic inflammatory states. Diagnosing this imbalance remains challenging, though, due to its diffuse symptoms and lack of standardized testing. Tailoring holistic intervention strategies for each patient can help improve outcomes through targeted nutrition and microbiome rebalancing. As with any treatment plan that requires dietary changes (temporary or not), practical challenges can arise during the recovery process.

What exactly is yeast overgrowth?

Candida, as it’s commonly understood in diagnoses, refers to an imbalance in the body’s microbiome where normally harmless yeast multiplies beyond its typical, healthy levels, causing dysfunction. Candida albicans is the culprit, a genus of yeast-like fungi that is a natural inhabitant of the mucosal microbiome, residing harmlessly on the skin, mucous membranes, and throughout the gastrointestinal, genital, and urinary tracts of healthy individuals.

Under healthy conditions, Candida coexists harmlessly with other microorganisms in the body. When the balance of our microbial ecosystem is disrupted, Candida can become opportunistic, shifting from a benign resident to a pathogenic organism that contributes to a range of symptoms and chronic illness.

When the immune system is weakened due to microbiome disruption from antibiotics or hormonal imbalances, it transforms into its invasive form. This shift enables C. albicans to adhere more strongly to epithelial cells and dig into mucosal barriers, leading to local infections such as vaginitis, oral thrush, and gastrointestinal dysbiosis. And, like something from a science fiction movie, the cell wall of C. albicans is designed for resistance and capable of withstanding physiological stress, which aids in tissue invasion and triggers inflammatory responses, particularly when the epithelial barrier is compromised.

This is, unfortunately, not a rare condition.

A cascade of common lifestyle choices and medical interventions can prime the system for fungal dysbiosis. Broad-spectrum antibiotics are perhaps the highest risk factor. They eliminate bacterial competitors, allowing Candida to flourish unchecked. A Western-style diet high in processed sugars and fat, and low in fiber, further fuels this overgrowth by degrading microbial diversity and altering the production of short-chain fatty acids in the gut.

Add to that the impact of hormonal birth control, pregnancy, or chronic stress, all of which shift the microbiome or weaken mucosal immunity. The stage is then set for a shift from an innocent organism to a pathogen that is harmful.

Widespread low-grade immune activation has become a common feature in modern health patterns. These patterns of symptoms may reflect underlying yeast overgrowth:

• Digestive stress

• Fatigue

• Chemical sensitivity

• Reproductive issues

Taking it a step further, diverse symptoms like these can be signs of an even greater fungal imbalance and compromised barrier integrity:

• Brain fog

• Joint pain

• Sugar cravings

• Bloating

• Mood swings

Recognizing the pattern and understanding how deeply it may be affecting your system can help guide an effective response. So how do you know if Candida is actually driving your symptoms? Here is a simplified framework to help gauge the level of involvement.

1. Mild symptoms: yeast may be contributing to your symptoms. At this level, yeast overgrowth is a co-factor, not a central driver, and you may experience symptoms such as sugar cravings, mild brain fog, or bloating; however, these symptoms are sporadic and manageable.

2. Moderate symptoms: yeast is likely the cause of your symptoms. Here, Candida overgrowth is likely a primary disruptor, and symptoms may include fatigue, recurring vaginitis, mood swings, and digestive stress, often chronic or cyclic in nature.

3. Severe symptoms: yeast is almost certainly involved. At this stage, overgrowth is likely entrenched and systemic, impacting digestion, cognition, mood, skin, and hormone function. Immune evasion is likely contributing to the persistence or recurrence of symptoms

In Part 2, I will lay out the exact steps to take, depending on the severity of your symptoms, ranging from gentle terrain support to more structured antifungal protocols.

If you enjoyed this article, please consider leaving a like on your way out, as it’s one of the quickest and cheapest ways to support my work. In advance, I am incredibly grateful. If you found the information useful, I’d love to hear in the comments!

Leave a comment

References

Faustino, M., Ferreira, C. M. H., Pereira, A. M., & Carvalho, A. P. (2025). Candida albicans: the current status regarding vaginal infections. Applied microbiology and biotechnology, 109(1), 91. https://doi.org/10.1007/s00253-025-13478-2

Jawhara S. (2023). Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection. Microorganisms, 11(6), 1556. https://doi.org/10.3390/microorganisms11061556

Kaur, J., & Nobile, C. J. (2023). Antifungal drug-resistance mechanisms in Candida biofilms. Current opinion in microbiology, 71, 102237. https://doi.org/10.1016/j.mib.2022.102237

Nobile, C. J., & Johnson, A. D. (2015). Candida albicans Biofilms and Human Disease. Annual review of microbiology, 69, 71–92. https://doi.org/10.1146/annurev-micro-091014-104330

Detoxification was built right into the whole magical design. There isn’t a hard cap on the number of toxins our body can filter, nor is there a workload limit on the liver. The body’s detox system is incredibly adaptive and resilient.

To be fair, though, the inputs have changed with modern life. We are now exposed to synthetic chemicals in our food, pesticides in our soil, microplastics in our water, endocrine-disrupting compounds… the list is depressingly long.

The issue with this inundation isn’t that our body stops detoxing from overload, and we need to gift it with a juice cleanse. The issue is that it becomes overburdened and dysregulated under chronic internal and environmental stress. The overburdened organs then slip into a state of inflammation or suboptimal function. This is especially true when the liver or gut lining is repeatedly asked to compensate for lifestyle choices that don’t support their natural rhythm.

So when we talk about detox today, we need to think bigger. Because your internal health is constantly responding to your external environment, it’s more than what you have (or don’t have) on your plate. It’s about what you allow (or don’t allow) into your personal ecosystem:

• your home

• your habits

• your environment

Your gut mirrors your environment

Over a decade ago, Dr. Elson Haas wrote in The Detox Diet that “gastrointestinal function and [soil] ecology are at the core of human health.” Back then, this perspective was still quite niche. Guts weren't trending, and “microbiome” wasn’t a household word. But the science has caught up. We now know that the gut plays a central role in immunity, metabolic balance, hormonal signaling, and even mood regulation. And it's not just what you eat, it's how your food is grown, what it is exposed to, and what microbial life still lives in or on it.

True detox starts with dirt

The health of our gut microbiome is deeply influenced by the health of the soil from which our food comes.

Microbial diversity in nutrient-rich soil closely mirrors the diversity in our gut. But modern agriculture is working against this.

Conventional farming practices like monocropping, over-tilling, and synthetic fertilizers destroy soil structure and microbial richness. Plowing breaks up fungal networks and releases carbon into the atmosphere. Monoculture depletes nutrients and fosters disease-prone crops that require heavy chemical inputs. Over time, this weakens the soil’s ability to support life, not just for plants, but also for humans who eat them.

Whole foods grown in healthy, living soil are fundamentally different from their industrial counterparts. They contain more phytonutrients, more microbial richness, and fewer synthetic residues. And when you eat them, you’re not just nourishing yourself, you are reinforcing your gut’s microbial network with the kind of diversity that promotes resilience.

“But organic is a scam!”

If I had a dollar for every Instagram reel I have seen espousing this belief, I could buy a yacht. Yes, organic can be inconsistently regulated. And yes, it’s been commodified in some circles. At its core, though, organic farming uses fewer and more natural pesticides and regenerative practices, which leads to healthier soil, which offers greater microbial diversity, which then leads to (you guessed it) a more diverse gut microbiome.

Ultimately, buying organic isn’t just a flex for almond moms. Choosing foods grown with care can protect your internal terrain from daily exposures that wear down your body’s ability to adapt and repair. But wait, there’s more.

It’s not just about what you eat, it’s what you absorb

Everything you put on your skin is all absorbed into your bloodstream and processed by your liver, kidneys, and other detox organs:

• beauty products

• cleaning spray

• face wipes

• laundry detergent, fabric softener, dryer sheets

• lotion, deodorant, perfume

• bottled water

Because our bodies are constantly working to maintain balance, it’s essential to support these systems as much as possible. And we can do that through micro decisions every day:

1. Eat whole, fiber-rich foods (preferably organic!): fiber helps bind and eliminate toxins from our system, and bonus, it feeds healthy bacteria in our gut.

2. Drink clean water: no-brainer, right? Just say ‘no’ to plastic bottles and filter wherever you can.

3. Use non-toxic makeup and healthcare products: eliminate anything with phthalates, synthetic fragrances, and parabens, as these are endocrine disruptors.

4. Detox your kitchen: BPAs, PFAS, and VOCs are all released from non-stick cookware and plastic food storage. Even the BPA-free plastic is toxic but that’s an entirely different post.

5. Avoid processed food: they contain emulsifiers and preservatives that are proven to induce inflammation and dysregulate our digestive process.

In conclusion

Detoxification should not be a quarterly protocol. It is a natural, ongoing function that requires support, not restriction. When you think of detox less as deprivation and more as nourishment and protection, we begin to see detox as a process of alignment between the body and its environment.

If you enjoyed this article, please consider leaving a like on your way out, as it’s one of the quickest and cheapest ways to support my work. In advance, I am incredibly grateful. If you found the information useful, I’d love to hear in the comments!

Leave a comment

References

Averina, O. V., Poluektova, E. U., Zorkina, Y. A., Kovtun, A. S., & Danilenko, V. N. (2024). Human Gut Microbiota for Diagnosis and Treatment of Depression. International journal of molecular sciences, 25(11), 5782. https://doi.org/10.3390/ijms25115782

Blum, W. E. H., Zechmeister-Boltenstern, S., & Keiblinger, K. M. (2019). Does Soil Contribute to the Human Gut Microbiome? Microorganisms, 7(9), 287. https://doi.org/10.3390/microorganisms7090287

Chiu, K., Warner, G., Nowak, R. A., Flaws, J. A., & Mei, W. (2020). The Impact of Environmental Chemicals on the Gut Microbiome. Toxicological sciences : an official journal of the Society of Toxicology, 176(2), 253–284. https://doi.org/10.1093/toxsci/kfaa065

Craven, M. R., & Thakur, E. R. (2024). The integration of complementary and integrative health and whole person health in gastrointestinal disorders: a narrative review. Translational gastroenterology and hepatology, 9, 75. https://doi.org/10.21037/tgh-23-121

Haas, E. M. (2012). The detox diet: The definitive guide for lifelong vitality with recipes, menus, and detox plans (3rd ed.). Ten Speed Press.

Hampl, R., & Stárka, L. (2020). Endocrine disruptors and gut microbiome interactions. Physiological research, 69(Suppl 2), S211–S223. https://doi.org/10.33549/physiolres.934513

It wasn’t a single injury or breakdown that made me stop, but a growing awareness that something deeper was off. My body was screaming, and I finally listened. I felt like I was slowly killing myself, and I didn’t understand why.

Now, armed with an understanding of the role our gut microbiome plays in our overall health and the body’s state of homeostasis, I realize that I’m fortunate to have retired from that life without developing an autoimmune or other chronic illness.

The science of why

The human gut is more than a digestive organ; it is a complex interface between the external environment and the immune system, tightly regulated by a network of microbial, epithelial, and biochemical signals. Among its most critical functions is maintaining a selective barrier: one that permits nutrient absorption while blocking harmful pathogens, toxins, and antigens from entering the circulation. This integrity hinges on the precise regulation of tight junction proteins and mucosal immunity, both of which are influenced by microbial composition and physiology. In recent years, research has begun to expand our understanding of how physical activity impacts gut health.

Exercise is capable of increasing bacterial diversity in the microbiome, enhancing mucosal immunity, and promoting the production of key short-chain fatty acids, which are crucial for digestive health. These changes are also linked to improved metabolic and immune function, reinforcing the idea that movement is medicine.

High-intensity and prolonged exercise, particularly in endurance athletes, may compromise gut barrier integrity, leading to a condition commonly referred to as “leaky gut.” Symptoms may reflect physiological changes other than just cramping and bloating, including increased intestinal permeability and low-grade inflammation.

While movement is essential to health, certain training loads may surpass the gut’s adaptive capacity, tipping it from resilience into dysfunction. Drawing from recent peer-reviewed studies, exercise-induced shifts in microbial balance and permeability are dose-dependent and, when excessive, may increase the risk of inflammation, immune dysregulation, and chronic disease in athletes.

Let’s explore the paradox

Intensity and duration of exercise play a crucial role in determining whether this influence is protective or detrimental. Across multiple studies, a consistent pattern emerges: high-intensity or prolonged exertion alters the gut microbiome, compromises intestinal barrier integrity, and increases the risk of systemic inflammatory signaling. These changes are subtle yet significant, particularly in athletes whose training exceeds adaptive thresholds.

Research indicates that exercise increases the abundance of bacterial genera that produce short-chain fatty acids, such as Faecalibacterium and Roseburia. These shifts are typically considered beneficial, as they enhance mucosal immunity, tighten epithelial junctions, and dampen pro-inflammatory pathways. However, the relationship is not linear.

At a certain threshold, especially in elite or overreaching athletes, the same microbial community can become destabilized, leading to increased zonulin and LPS proteins

The integrity of the intestinal barrier hinges on the regulation of tight junction proteins, which are directly influenced by microbial metabolites and stressors. Exercise-induced heat, low oxygen intake, and oxidative stress degrade these proteins, opening pathways that allow microbial fragments and endotoxins to enter the bloodstream. This break is not benign because elevated protein levels post-exercise indicate epithelial damage and acute immune response, even when GI symptoms may be absent.

Microbiota composition plays two roles: it can either reinforce the gut’s defensive architecture or exacerbate its breakdown, depending on the training load, energy availability, and individual susceptibility. Notably, some studies indicate sex- and age-specific differences in microbial resilience, suggesting that women and older athletes may be at greater risk for dysbiosis-induced permeability.

The clinical implications are not trivial, as systemic inflammation originating in the gut has been linked to a range of conditions, including metabolic syndrome, neuroinflammation, and autoimmune disease. In performance settings, compromised gut health may manifest as nutrient malabsorption, immune suppression, or mood instability, none of which are conducive to achieving sustainable training outcomes.

Ways to protect your athletic biome

1. Fuel early and often: prioritize pre- and post-workout nutrition, especially around long or intense sessions.

2. Don’t train through dehydration: add electrolytes to your water.

3. Ease into intensity: your biome needs time to adapt to higher training volumes and stress; avoid sudden jumps in duration or intensity, and prioritize active recovery between hard sessions.

4. Eat for diversity: aim for 30+ different plant foods per week including fruit, veg, herbs, nuts, seeds, beans, and prebiotics like garlic, onion, and oats.

5. Watch for subtle signs: mood swings, sleep disruption, frequent illness, joint pain can all be signs your gut is under stress; scale back temporarily and prioritize recovery.

6. Train your gut like a muscle: practice eating during workouts especially if you race; the gut is trainable and GI distress during long events often comes from underuse not overuse.

In conclusion

While moderate physical activity supports microbial diversity and barrier resilience, training beyond physiological thresholds can disrupt tight junction integrity, increase translocation of endotoxins, and trigger low-grade inflammation. These effects may not manifest as overt symptoms but can erode long-term health and performance, particularly in athletes who train through fatigue, dehydration, or under-recovery.

The studies reviewed collectively suggest a dose-response relationship between exercise and gut function, which is modulated by microbial balance, immune signaling, and individual factors such as sex, diet, and baseline fitness.

Although more research is needed to standardize measurement, the implications are clear: the gut is not a passive participant in athletic adaptation; it is an active participant and often the first to show signs of overload.

Recognizing gut permeability as both a modifiable risk and a potential biomarker for training tolerance may shift how we approach recovery, nutrition, and resilience in high-performing populations. Moving forward, integrating gut health into performance frameworks is more than preventing GI distress; it is about supporting whole-system integrity in the pursuit of long-term vitality.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

Leave a comment

References

Al-Beltagi, M., Saeed, N. K., Bediwy, A. S., El-Sawaf, Y., Elbatarny, A., & Elbeltagi, R. (2025). Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity. World journal of gastroenterology, 31(22), 106835. https://doi.org/10.3748/wjg.v31.i22.106835

Aya, V., Flórez, A., Perez, L., & Ramírez, J. D. (2021). Association between physical activity and changes in intestinal microbiota composition: A systematic review. PloS one, 16(2), e0247039. https://doi.org/10.1371/journal.pone.0247039

Boytar, A. N., Skinner, T. L., Wallen, R. E., Jenkins, D. G., & Dekker Nitert, M. (2023). The Effect of Exercise Prescription on the Human Gut Microbiota and Comparison between Clinical and Apparently Healthy Populations: A Systematic Review. Nutrients, 15(6), 1534. https://doi.org/10.3390/nu15061534

Dmytriv, T. R., Storey, K. B., & Lushchak, V. I. (2024). Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise. Frontiers in physiology, 15, 1380713. https://doi.org/10.3389/fphys.2024.1380713

Dziewiecka, H., Ostapiuk-Karolczuk, J., Kasperska, A., Cichoń-Woźniak, J., Basta, P., & Skarpańska-Stejnborn, A. (2025). Effect of 2000-meter rowing test on parameters of intestinal integrity in elite rowers during competitive phase - observational study. BMC sports science, medicine & rehabilitation, 17(1), 52. https://doi.org/10.1186/s13102-025-01099-1

Hawley, J. A., Forster, S. C., & Giles, E. M. (2025). Exercise, the Gut Microbiome and Gastrointestinal Diseases: Therapeutic Impact and Molecular Mechanisms. Gastroenterology, 169(1), 48–62. https://doi.org/10.1053/j.gastro.2025.01.224

Macura, B., Kiecka, A., & Szczepanik, M. (2024). Intestinal permeability disturbances: causes, diseases and therapy. Clinical and experimental medicine, 24(1), 232. https://doi.org/10.1007/s10238-024-01496-9

Min, L., Ablitip, A., Wang, R., Luciana, T., Wei, M., & Ma, X. (2024). Effects of Exercise on Gut Microbiota of Adults: A Systematic Review and Meta-Analysis. Nutrients, 16(7), 1070. https://doi.org/10.3390/nu16071070

Peng, M., Zou, R., Yao, S., Meng, X., Wu, W., Zeng, F., Chen, Z., Yuan, S., Zhao, F., & Liu, W. (2024). High-intensity interval training and medium-intensity continuous training may affect cognitive function through regulation of intestinal microbial composition and its metabolite LPS by the gut-brain axis. Life sciences, 352, 122871. https://doi.org/10.1016/j.lfs.2024.122871

Varghese, S., Rao, S., Khattak, A., Zamir, F., & Chaari, A. (2024). Physical Exercise and the Gut Microbiome: A Bidirectional Relationship Influencing Health and Performance. Nutrients, 16(21), 3663. https://doi.org/10.3390/nu16213663

Yun, S., Seo, Y., Lee, Y., & Lee, D. T. (2024). Gut microbiome related to metabolic diseases after moderate-to-vigorous intensity exercise. Journal of Exercise Science & Fitness, 22(4), 375-382. https://doi.org/10.1016/j.jesf.2024.07.003